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Lymphatic dysfunction plays a key role in pathologies such as immune disorders, infection, 
cancer, obesity, and cardiovascular disease; regarding the latter, lymphatic dysfunction 
may exacerbate edema in myocardial infarction (MI) and chronic heart failure. Secondary 
lymphedema is a progressive and debilitating disease characterized by fluid retention and 
tissue swelling that can arise due to dysfunction in lymphatic pumping. Secondary 
lymphedema is a common complication in breast cancer treatment where the surgical 
removal of lymphatic vessels/lymph nodes can induce overloads that triggers lymphatic 
pathologies that can present months or even years after surgery. Although the local 
mechanical environment is known to regulate lymphatic function, the role of sustained 
mechanical overloads (e.g., high pressure and high flow) in lymphatic dysfunction has yet 
to be established. Towards this end, our long-term goal was to develop a mechanistic 
understanding of mechanically-mediated growth and remodeling (G&R) of collecting 
lymphatic vessels in health and disease and to ultimately identify novel therapeutic 
interventions to minimize the risk of occurrence, severity, or complications of lymphatic 
dysfunction.  This PhD thesis focuses on developing a novel rat tail model to study 
lymphatic G&R and to employ a combined experimental-computational approach to 
quantify the modes by which sustained high pressure and high flow compromise the normal 
function of the lymphatic system via maladaptive remodeling. First, we introduced and 
used a novel rat tail model to study the effect of mechanical loads (specifically axial stretch) 
on the lymphatic contractility. Second, we developed a computational framework to study 
lymphatic pumping in the context of a lymphangion chain. Lastly, we developed and tested 
xviii 
 
the feasibility of a novel lymphatic ligation model to study lymphatic remodeling post-
surgery. Lastly, the methods and results from this study can pave the way for future studies 
of lymphatic remodeling in health and disease. 
 
 1 
CHAPTER 1. INTRODUCTION AND BACKGROUND 
1.1 Lymphatic function and physiology. 
The lymphatic system found in most soft tissues is fundamental to maintaining 
tissue fluid balance, immune function and absorption and transport of lipids [1]. A 
hierarchical architecture enables the lymphatic system to transport lymph from 
interstitial spaces through specialized lymphatic capillaries, towards pre-collecting, 
prenodal and postnodal collecting vessels that return lymph back to the great veins [2]. 
Since the lymphatic system does not have a central pump to propel fluid within the 
network, collecting lymphatic vessels have been equipped with specialized smooth 
muscle cells capable to generate intrinsic contractions. In addition, intraluminal valves 
that separate each functional unit, called a lymphangion, ensure unidirectional flow 
within the network. Since collecting lymphatic vessels serve as both a conduit and a 
pump, modulation of lymphatic pumping is subject to chemical [3–6], mechanical [7–
10] as well as electrical regulations [11–14]. Mechanical regulation is known to be an 
integral part of spontaneous contractions of lymphatic vessels [10,15–17]. Generally, 
increases in pressure/stretch initiate spontaneous contractions while increases in 
flow/shear inhibit contractions[18]. However, there exists a regional heterogeneity in 
lymphatic structure and function to adapt to particular flow and pressure conditions in 
different regions[17].  
Fluid shear and pressure forces have well-established roles in the regulation of 
lymphatic function[2,4,8–10]. It is well known that fluid shear stress modulates 
frequency and amplitude of phasic contractions as well as endothelial-dependent nitric 
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oxide synthesis [3]. In addition, it has been suggested that shear stress regulates the 
complex process of lymphatic vessel and intraluminal valve maturation and 
development [19,20]. Similarly, transmural pressure can regulate frequency and 
amplitude of contractions, lymphatic tone as well as active length-tension 
relationships. Further, transmural pressure modulates valve gating which dictates 
unidirectional flow within lymphatic vessels[21]. Although lymphatic vessels respond 
to alterations of flow and pressure overload to maintain normal function, prolonged 
overloads can trigger maladaptive remodeling which compromises normal function. 
The enlargement of collecting lymphatic vessels in the presence of growth factors such 
as VEGFC has been attributed to increased lymph flow[22]. Additionally, histological 
and morphological changes in collecting lymphatic vessels such as the growth of 
collagen fibers, phenotypic change in lymphatic MCs, sclerosis and lumen narrowing 
have also been reported to associate with intraluminal pressure and flow overloads[23].  
1.2 Lymphatic dysfunction and Lymphedema. 
A dysfunctional lymphatic system not only causes pathologies but it can also 
exacerbate other diseases. Lymphatic impairment has been implicated in numerous 
diseases such as atherosclerosis [24–26], myocardial infarction[27–29], heart failure 
[30], lung diseases [31,32], cancer [22,33–35] and most of the inflammatory [36,37] 
and edema related pathologies[38,39]. Secondary lymphedema is a chronic, 
debilitating condition due to an impairment of lymphatic function during cancer 
treatment. Since an impaired lymphatic system is not capable to effectively transport 
lymph, fluid retention and tissue swelling occur in patients afflicted with lymphatic 
pathologies. Recent reports have suggested that blockade of lymph flow due to  
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surgical procedures as well as high lymph drainage due to edema and fluid retention 
can play an important role in the pathogenesis and progression of lymphatic disorders 
[40,41]. Insufficiency of the lymphatic system is mainly attributed to impaired intrinsic 
contraction of lymphatic vessels to effectively transport lymph. Additionally, other 
complications such as fat and protein accumulation, increase in adipose tissue and 
immunosuppression are known to be associated with an impaired lymphatic 
system[38,42,43]. Since the lymphatic system is a dynamic complex that adapts to 
alteration in working conditions, remodeling of lymphatic vessels is regarded as an 
important factor that causes lymphatic dysfunction [35,44,45]. 
1.3 Current state of animal models in lymphatic research  
To study lymphatic function a variety of both large animals and small animal models have 
been used [46–48]. Currently, rodents play a key role in lymphatic research and most 
results are generated based on these models. Specifically, available rodent’s models have 
been extensively used to develop our understanding of the lymphatic system [49–52]. 
There are postsurgical models of lymphedema that closely simulate the human conditions 
of primary and secondary lymphatic insufficiency. To study lymphatic disease, specifically 
lymphedema, a combined approach of skin excision, lymph node removal and radiation 
has been successfully used. The incision and cauterization of hind limb and tail tissue beds 
have been used to induce lymphedema in rodents [53,54]. Large animal models have been 
successfully used to study acquired lymphedema in dogs, sheep, and pigs [55–57]. Such 
models will help to refine the assessment of various therapeutic approaches and their 
potential applicability to human disease interventions. One challenge with surgically 
induced lymphedema in rodents is the fact that swelling resolves if given enough time [58], 
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however, secondary lymphedema is permanent in humans and occurs months to years after 
surgery. 
1.4 Emerging techniques in lymphatic imaging 
Near-infrared (NIR) fluorescence lymphatic imaging has emerged as a successful tool and 
has gained attention in recent years. Using fluorescent dyes, NIR imaging technologies 
have provided a solution for functional imaging of the lymphatic system in clinical and 
research settings. Indocyanine green (ICG) has gained attention in optical diagnosis of 
lymphatic function, however, this dye first was approved in the 1950s to assess cardiac 
function. Additionally, several effluent dyes such as Evans blue and Trypan Blue have been 
tested via subcutaneous and intradermal injection to map and visualize lymphatic vessel 
and lymph nodes. Several groups have used the near infrared imaging technique (NIR) to 
study lymphatic function in rodents. In particular, this technique has been successful to 
provide insightful information regarding lymphatic function in post-lymphatic surgery 
[54,59]. 
Computational modeling has emerged as a useful tool to shed light on the salient 
features of lymphatic  function. Several groups have developed models to study lymphatic 
pumping based on mathematical models and experimental observations for collecting 
lymphatic vessels [60,61,70,71,62–69]. These computational models have been used to 
provide insight into lymphatic pumping under optimal working conditions; however, most 
of these studies are based on a single experimental observation in an ex-vivo or in-vivo 
study and conflicting results have been reported [72,73].  There have been efforts to 
constitutively model the passive and active mechanics of lymphatic vessels based on the 
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hyperelasticity theory and ex-vivo experiments [70]. This framework has been successfully 
used to fit experimental data from the rat thoracic duct. Furthermore, an algorithm was 
developed to use this framework coupled with a valve model to perform parametric studies 
of lymphatic adaptation to different loading conditions [71,74]. Yet, computational models 
based on the specific experimental results to study lymphatic growth and remodeling is 
lacking. There is a need to develop computational models based on specific experimental 
data from the tissue bed being modeled in order to enable prediction of changes in 
lymphatic pumping in disease scenarios. 
1.5 Specific Aims  
A prime example of a lymphatic disorder is secondary lymphedema, a progressive and 
debilitating disease mainly associated with fluid retention and tissue swelling among 
patients having or undergoing treatment for malignancy. The surgical removal of lymphatic 
vessels/nodes is known to be a potential risk factor to develop lymphedema even months 
to years after surgery and this risk is further increased with radiation and/or particular 
chemotherapeutic treatments. An impaired lymph circulation can induce overloads, 
ultimately leading to microstructural remodeling prior to the onset of lymphatic 
pathologies.  
Although mechanical stresses are known to be fundamentally important regulators of 
lymphatic function, the role of sustained overloads (high flow and high pressure) in 
lymphatic dysfunction has yet to be established. Our long-term goal was to develop a 
mechanistic understanding of the active role of mechanics in growth and remodeling 
(G&R) of collecting lymphatic vessels in health and disease, and to ultimately have a better 
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understanding of mechanical culprits in lymphatic dysfunction. The general objective of 
my thesis was to experimentally and computationally investigate the modes by which 
sustained high flow and high pressure compromise normal function of the lymphatic 
system. It’s been proposed that growth and remodeling (G&R) due to to disruption of 
mechanical loading occurs in three time scales: First, an immediate mechanical response 
through which solid and fluid mechanics of collecting lymphatic vessel alter and second, 
an acute response to compensate for changes in vessel function due to overloads. This step 
has been proposed to be mediated by biochemical agents released in response to overloads 
that occurs in minutes to hours time-scale. Third, a long-term remodeling response that 
alters material properties, geometry and function of vessels in days to months time-scale. 
 
Figure 1. 1 A representation of the time course of lymphatic adaptation and G&R response to 
mechanical loads [70]. 
To develop a better understanding of the short-term and long-term remodeling response, 
we propose the following Aims:  
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Figure 1. 2 An overview of the three aims to study lymphatic G&R. Aim 1 investigates 
biomechanical properties of lymphatic vessels via an experimental approach to study the contractile 
response of rat tail lymphatics to the immediate and acute perturbations in mechanical and 
biochemical stimuli. Aim 2 establishes a theoretical framework based on the constitutive modeling 
of lymphatic wall mechanics to study lymphatic pumping and alteration in contractile function in 
response to immediate and acute perturbation of mechanical and biochemical stimuli in the context 
of a lymphangion chain. Aim 3 investigates structural and functional remodeling of collecting 
lymphatic vessels in response to lymphatic injury via a novel rat tail ligation model. 
Aim 1: To experimentally quantify the acute response of collecting lymphatic vessels to 
mechanical stretch (pressure and axial stretch) as well as biochemical agents (e.g., nitric 
oxide (NO)) via a novel rat tail model. There are two milestones for Aim 1 as follows: 
Milestone 1.1: To characterize the effect of axial stretch under a controlled biaxial load on 
lymphatic contractility via ex-vivo experiments on the isolated rat tail lymphatic vessels. 
Hypothesis 1.1: Acute perturbations in the axial stretch, as well as pressure, modulate 
lymphatic contractions in rat tail lymphatics. 
Milestone 1.2: To characterize the effect of exogenously administered NO on lymphatic 
contractility via ex-vivo experiments on the isolated rat tail lymphatic vessels. 
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 Hypothesis 1.2: Exogenous NO inhibits lymphatic contractility of rat tail lymphatics in a 
dose-dependent manner. 
To achieve this aim, I used isolated vessel experiments on the rat tail lymphatics where a 
segment of a lymphatic vessel is dissected and mounted on opposing cannulas in a custom-
designed vessel chamber that allows for control of both axial stretch and transmural 
pressures. Histology and two-photon imaging are also used to investigate the 
microstructure of isolated lymphatic vessels. 
Figure 1. 3 An illustration of experimental setup (isolated vessel experiments) and 
histological approach used in Aim 1. 
Aim 2: To establish a microstructurally motivated chemo-biomechanical framework 
based on the experimental observations in Aim1 to model the passive and active responses 
of rat tail lymphatic vessels to mechanical/biochemical perturbation (axial stretch and 
nitric oxide). There are three milestones for Aim 2 as follows: 
Milestone 2.1: To determine the material parameters that describe the passive constituents 
of rat tail lymphatics and the variance of these parameters using a microstructurally-
motivated model and a bootstrapping technique. 
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Hypothesis 2.1: Using the bootstrapping technique enables us to determine the unique 
intraspecific biomechanical properties of rat tail lymphatics 
Milestone 2.2: To develop a computational framework to model the effect of exogenous 
NO and axial stretch on lymphatic contractility. 
Hypothesis 2.2:  Changes in lymphatic contractility due to axial stretch and NO 
administration can be modeled via the effects of NO on force production by lymphatic 
muscle cells and the effects of axial loading on circumferential stretch and length-tension 
relationships describing lymphatic force production in the circumferential direction.   
Milestone 2.3: To develop an algorithm for modeling a chain of contracting lymphangions 
based on the constitutive modeling approach to characterize the maximal pressure 
generation capacity of the lymphatic chain. 
Hypothesis 2.3:  The maximal pressure generation capacity of the lymphangion chain 
depends on the number of lymphangions in the chain, the force generation capacity by the 
lymphatic muscle cells, and thus will be reduced by exogenous NO administration. 
To achieve this aim, I use a constitutive framework to model passive biomechanics of 
lymphatic vessels, an active model for force production by lymphatic muscle cells, and a 
valve model to simulate the function of intraluminal valves. Ultimately, all these models 




Figure 1. 4 A schematic figure of the computational frameworks used to model a lymphangion 
chain The constitutive equation is a four-fiber family model originally developed by Caulk et al 
[75].  
Aim 3: To develop a novel ligation model in the rat tail to study the prolonged 
adaptations of collecting lymphatic vessels to mechanical overloads. There is one 
milestone for Aim 3 as follows: 
Milestone 3.1: Developing a novel lymphatic injury model in the rat tail and testing the 
feasibility of using this animal model to study load-induced remodeling in collecting 
lymphatic vessels via in-vivo imaging and ex-vivo experiments on the isolated vessels. 
Hypothesis I: I test whether the surgical removal of relatively large segments of lymphatic 
vessels from one side of the tail triggers a remodeling response resulting in a progressive 
decline in lymphatic function. 
To achieve this aim, I use longitudinal functional near-infrared (NIR) imaging, ex-vivo 
experiments on the isolated lymphatic vessels and histology to study lymphatic remodeling 
via the novel rat tail model. 
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Figure 1. 5 A schema of proposed novel lymphatic ligation model and experimental approaches to 
study lymphatic remodeling post-lymphatic injury. 
From these specific aims, I elucidate the role of sustained overloads in remodeling of collecting 
lymphatic vessels through both experiment and computation. To date, there has not been a 
specific quantitative or experimental framework to predict functional, microstructural and 
morphological consequences of non-compensatory/pathophysiological remodeling in 
lymphatic vessels. The goal of my PhD thesis was to provide a framework to study 
mechanically mediated G&R based on the specific data capturing the biomechanics and 
function of collecting lymphatic vessels over G&R time courses. Currently, most patients 
cannot be diagnosed until late into the progression of lymphatic dysfunction.  The results of 
this work might provide a better understanding of the modes by which mechanics impairs 
lymphatic structure and function, and may provide insight into earlier diagnosis and improved 
therapeutic strategies for lymphedema disease. 
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CHAPTER 2. THE ROLE OF AXIAL STRETCH AND NITRIC 
OXIDE IN LYMPHATIC CONTRACTILITY 
2.1 Aim 1 
In this chapter, I experimentally quantify the acute response of collecting lymphatic 
vessels to mechanical stretch (pressure and axial stretch) as well as biochemical agents 
(e.g., nitric oxide (NO)) via a novel rat tail model. My hypothesis is that the axial stretch 
and exogenous NO are modulators of lymphatic contractility in these rat tail vessels. There 
are two milestones associated with this aim.  
Milestone 1: To characterize the effect of axial stretch under a controlled biaxial load on 
lymphatic contractility via ex-vivo experiments on the isolated rat tail lymphatic vessels. 
Hypothesis: Acute perturbations in the axial stretch, as well as pressure, modulate 
lymphatic contractions in rat tail lymphatics. 
Milestone 2: To characterize the effect of exogenously administered NO on lymphatic 
contractility via ex-vivo experiments on the isolated rat tail lymphatic vessels. 
Hypothesis: Exogenous NO inhibits lymphatic contractility of rat tail lymphatics in a dose-
dependent manner. 
2.1.1 Introduction  
Lymphatic vessels serve as the major route to transport lymph from the interstitial 
space to the great veins [18,76,77]. Collecting lymphatic vessels play a key role in 
 13 
lymphatic transport as they serve as a pump to propel lymph against an adverse pressure 
gradient [18]. These vessels have specialized smooth muscle cells (SMCs) that enable them 
to contract spontaneously [10]. The vessels’ rhythmic and synchronized contractions are 
orchestrated to propel lymph in an efficient way along the chain of vessels [78,79]. In 
addition, lymphatic vessels exhibit tonic constrictions (maintained contractions) to control 
vessel caliber [18,80]. Mechanical stimuli (e.g., pressure and flow), as well as biochemical 
stimuli (e.g., vasoactive agents such as nitric oxide), are believed to be key regulators of 
lymphatic contractility. 
Although mechanical regulation of lymphatic vessels in response to flow and 
pressure are well documented, less is known about the role of axial loading in the 
modulation of lymphatic function. To date, there is no information available on the role of 
axial stretch on lymphatic contractility. The majority of information on lymphatic 
contractility is based on isolated vessel experiments in which vessels are excised out of 
their natural environment. Although it has not been documented formally in the literature, 
from isolated vessel experiments it is known that a lymphatic vessel requires a level of 
axial pre-stretch to enable contractions. For the reasons mentioned above, it is important to 
consider the role of axial loading on lymphatic contractility and quantify the role of axial 
loading and axial contractility on lymphatic function.  
The purpose of this chapter is to provide experimental evidence of the significance 
of axial pre-stretch on the modulation of lymphatic contractions through ex vivo isolated 
vessel experiments in rat tail lymphatics. I developed a novel rat tail model to test the 
hypotheses that lymphatic vessels are under pre-axial stretch in situ and that axial stretch 
modulates lymphatic contractions. Using isolated vessels experiments along with 
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immunostaining, I quantified the effect of axial stretch on lymphatic contractility and 
examined the organization of lymphatic SMCs and collagen fibers and their contributions 
to the physiological function of lymphatic vessels.  
2.1.2 Methods 
2.1.2.1 Animal model and vessel isolation procedure. 
 An incision (~1 cm) was made in one side (left or right side) near the base of the 
tail to gain access to the lateral tail vein of male Sprague Dawley rats (300-350 g), with 
care taken to avoid injury to the lateral vein or artery. Trypan Blue Solution 0.4% dye was 
injected upstream of the incision site to enhance the visibility of lymphatic vessels. Under 
a stereo microscope, a lymphatic chain that runs parallel to the lateral vein was visualized. 
Segments of lymphatic vessel (~2mm) were excised. Once isolated, vessels were placed in 
Dulbecco’s Phosphate Buffered Saline (DPBS, Corning). After removing the surrounding 
fat and connective tissues, lymphatic vessels (containing approxiamtely1-2 valves) were 
mounted on opposing cannula in a custom-made vessel chamber [75]. The protocol for 
these experiments was approved by Georgia Tech's Institutional Animal Care and Use 
Committee (IACUC). 
2.1.2.2 Experimental setup, protocol, and data acquisition. 
 We improved a previously developed perfusion device to measure and control 
transmural pressure, diameter, and axial stretch [81]. A custom program in LabVIEW was 
developed to control transmural pressure via a syringe pump (Harvard) and pressure 
sensors (1psi SSC series, Honeywell). Axial stretch was precisely controlled via linear 
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actuators and XYZ stages (Newport Precision, LTA series and M-461 series). This system 
was placed on an inverted microscope and the contractility response of the mounted vessel 
under different transmural pressures/axial stretches was measured. Using the LabVIEW 
program, the diameter of the vessel, obtained from an inverted microscope (2.5x 
magnification) and digital camera (Allied Vision Technologies, Marlin F-033B) capturing 
at 18 fps tracing, was recorded in real-time and saved to the hard drive for further analysis. 
In a temperature-controlled bath containing DMEM/F-12 (Dulbecco's Modified Eagle 
Medium/Nutrient Mixture F-12 plus Pen-Strep 1:100, pH=7.4 at 37℃) [82], the vessel was 
equilibrated for ~1hr to develop stable contractions. For the stretch protocol, the vessel was 
preconditioned and then the pressure was held constant at 2mmHg while three stretch steps 
of 10%, 20%, and 30% were used respectively. The axial stretch was measured with respect 
to the buckling length as described in the next section. These values were chosen based on 
a pilot study to determine the pressure at which contractions are maximum. 
2.1.2.3 Measurement of axial stretch in-vivo.  
To measure in-situ stretch, the animal was placed under a ZEISS dissecting 
microscope equipped with an AxioCam MRc 5 (ZEISS inc) camera. After removing the 
skin from the base of the tail, Trypan blue (0.4%) was injected to the tip of tail to enhance 
the visibility of a lymphatic vessel under the microscope. After removing the perivascular 
tissue, pins (0.2 mm diameter, Fine Science Tools inc) were used to mark the length of the 
segment prior to dissection. Using microsurgical scissors, a segment of lymphatic vessel 
located between two pins was dissected.  Subsequently, ImageJ software was used to 
determine in-situ stretch. Further, to measure axial stretch in-situ under physiological 
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pressure a single vessel was tied off prior to the dissection and the same procedure was 
repeated.    
 
2.1.2.4 Measurement of axial stretch ex-vivo.  
To determine ex-vivo stretch, vessels were preconditioned in a temperature-
controlled bath for ~1 hr. Once the vessels were preconditioned, buckling length was 
determined via an inverted microscope equipped with a camera( Marlin Allied vision) to 
measure the vessel’s length as well as precision linear micrometer actuators (Newport) to 
linearly change position of the micropipettes.   The buckling length was defined as the 
minimum axial length required to the keep vessel straight where the vessel is not collapsed 
at nearly zero pressure( ~0-0.5 mmHg).  Next, the vessel length was measured between 
two sutures on glass pipettes using a custom-written LabView code.  Subsequently, stretch 
was increased to 10%, 20% and 30% using precision micromanipulators (Fig. 2.1), 
respectively. Ultimately, vessel contractions were recorded at different axial stretches at a 
transmural pressure of 2mmHg.  
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Figure 2. 1 A schematic diagram of ex-vivo measurement of axial stretch using ex-vivo setup. The 
vessel was pressurized at ~0.5mmHg to determine unloaded geometry. Axial stretch was 
determined with respect to the length at which vessel is not buckled. 
2.1.2.5 Contractility metrics and statistics.  
A custom-written MATLAB (MathWorks) program was used to calculate end-
systolic diameter (ESD), end-diastolic diameter (EDD), and contraction frequency (FREQ) 
based on the raw data obtained during experiments. Subsequently, several metrics of 
lymphatic pumping were calculated including amplitude (AMP), ejection fraction (EF), 
fractional pump flow (FPF) as: 
Amplitude: (AMP) = (EDD-ESD) 
(1) 
Ejection fraction: (EF) = [EDD2-ESD2]/ EDD2   (2) 
Fractional pump flow: (FPF) = EF× FREQ (3) 
Data obtained from the stretch protocol were plotted as a function of stretch. To determine 
statistical significance, a one-way ANOVA in conjunction with Bonferroni’s post hoc 
correction was used to make multiple comparisons. Prism 5 (GraphPad Software) was used 
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to perform all statistical analyses with significance set at p < 0.05 and results were reported 
as means (±SEM). 
2.1.2.6 Whole-mount immunofluorescence staining. 
 Rat tail lymphatic vessels were isolated and fixed for two hours in 4% PFA at room 
temperature. After fixing, the vessel was washed three times with PBS and blocked with 
5% goat serum in PBS and 0.5% Triton X-100 for 1-2 hours , followed by addition of the 
primary antibody (1:100; α-SMA Sigma) and incubation for 48 hours overnight at 4ºC 
(primary antibody was replaced with fresh one after 24 hours). After washing in PBSTx 
(0.3% Triton X-100 in PBS) three times, the sample was incubated in secondary antibody 
at room temperature for 2 hours (1:1000, Alexa Fluor® 488, goat anti-mouse antibody). 
After finishing the staining, the vessel was washed in PBSTx three times and mounted in 
Prolong Gold for imaging. 
2.1.2.7 Confocal and SHG image acquisition. 
 Confocal images of collecting lymphatic vessels from rat tails were acquired using 
a Zeiss LSM 710 system with 40x/1.3 and Plan-Apochromat 63x/1.4 oil-immersion 
objectives. The images of z-stacks were imported in ZEN lite (Zeiss) software to obtain 
3D reconstructions. The second harmonic generation (SHG) of collagen fibers were 
obtained under 800 nm excitation wavelength. The orientation of fibers in acquired images 
was obtained using CT_FIRE software that automatically extracts individual fibers by 
applying the curvelet denoising filter followed by an automated fiber extraction method 
[83]. The orientation of the nuclei was obtained from DAPI staining and analyzing the 
respective images with CellProfiler software [84]. 
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2.1.2.8 Collagenase experiments 
To test whether the axial collagen constrains the length of lymphatic vessels, the vessel 
was treated with collagenase (Collagenase Type II ) for 30 minutes.  Once mounted in the 
vessel chamber containing PBS (Ca free) and treated with collagenase, changes in the 
length and diameter of vessel were measured using a custom-written LabView program. In 
addition, pressure-diameter curves were obtained at different axial stretches before and 
after collagenase treatment. Both the length and diameter of vessel increased after collagen 
degradation. The results suggest collagen fibers plays a significant role in constraining 
longitudinal and circumferential dimensions. 
 
2.1.3 Results 
Rat tail lymphatic vessels are under axial pre-stretch in vivo and increased axial 
stretch decreases contractility ex vivo.  The results showed that collecting lymphatic 
vessels from rat tails experience significant axial stretch (𝜆𝑧 = 1.24 ± 0.03) in situ (Figure 
2.1). The amplitude of contractions decreased as the stretch increased from 10% to 20%, 
however, a more significant reduction (50µm equal to ~90% reduction) occurred for the 
higher stretch of 30% (Figure 2.2).  
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Similar trends were observed for the frequency, which decreased from 15 min-1 to less than 
5 min-1 (~80% reduction), the ejection fraction, which decreased from 46% to 9% (~80% 
reduction), and the fractional pump flow, which decreased from 6.8 min-1 to 0.58 min-1 
(~92% reduction). Notably, contractility metrics, (e.g. ejection fraction) slightly decreased 
at 20% stretch, however, the 30% stretch significantly changed contractility and almost 
inhibited phasic contractions. The results demonstrate that collecting lymphatic vessels 
contractility is sensitive to axial stretch. 
Figure 2. 2 A schematic diagram showing (Panel A) chains of lymphatic vessel in rat tails, an image of the 
location where an incision was made to gain access to the lymphatic vessel close to the base of tail, showing 
that the lymphatic vessel runs parallel to the tail vein and arteries, and (Panel B) an image showing lymphatic 
vessels from rat tails are under axial stretch in situ and (Panel C) a single measurement of axial stretch in-situ 
under physiological pressure (Panel D). The vessel has been tied off and is under 12% axial stretch. 
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Figure 2. 3 Effect of axial stretch on contractile function of lymphatic vessels. The contractile 
parameters were plotted as a function of the axial stretch (n=5), including amplitude of contractions 
(AMP; Panel A), frequency of contractions (FREQ; Panel B), ejection fraction (EF; Panel C), 
fractional pump flow (FPF; Panel D)., Panel E shows an image of a rat tail lymphatic vessel 
cannulated on glass micropipettes along with respective raw traces of contractions at different 
stretches. The pressure was set to 2mmHg for all experiments. All data are presented as mean (±SE) 
and statistical significance was tested via ANOVA and Bonferroni post-hoc tests (* p < 0.05, ** p 
< 0.005) 
Collagen fibers are predominantly oriented in the axial direction.  The analysis of 
collagen fibers showed that the probability of fiber angle distribution was maximum in the 
axial direction while the minimum occurred in the circumferential direction (Figure 2.3). 
Further, imaging of collagen fiber orientation at high pressure (p≅8mmHg), and 
comparison of the results to images at low pressure (p≅2mmHg), revealed that increasing 
the pressure does not change the maximum probability of fiber alignment in the axial 
direction. However, the circumferential orientation slightly increased (< 5%) suggesting 
most collagen fibers are oriented in the axial direction even at high pressures. At 
physiological pressure, the distribution was normal with a maximum near the axial 
direction (~70% of fibers, -30 < α < 30). 
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Figure 2. 4 Collagen fiber organization within the wall of a pressurized, unfixed rat tail lymphatic 
vessel in tubular and valvular regions including reconstruction of SHG imaging of collagen fibers 
along with dorsal view ventral views (Panel A), the z-stack images obtained from SHG imaging of 
collagen fibers and respective fiber extractions using CT-FIRE algorithm (Panel B), distribution of 
collagen fiber angles  (Panel C),  distribution of collagen fiber straightness within the vessel wall 
for low (~2 mmHg) and high (~8mmHg) pressure scenarios (Panel D), and the average distribution 
of collagen fibers obtained from five vessels plotted as the mean value along with the standard 
deviation (Panel E, the width of each bin is 200 and values of x-axis indicate the center of each bin). 
The vessels were excised from the base of the tail and mounted on glass pipettes in a custom-made 
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vessel chamber compatible with the microscope. The vessels were unfixed, the pressure was ~2 
mmHg, and the axial stretch was ~10%. 
Orientations of lymphatic SMCs are heterogeneous, covering both axial and 
circumferential directions. Whole mount staining for α-SMA and DAPI staining for 
nuclei revealed one dense layer of lymphatic MSc with the occasional second layer 
(Figures 2.4 and 2.5). The layers of lymphatic SMCs showed different patterns in tubular 
Figure 2. 5 Lymphatic smooth muscle coverage and fiber organization in collecting lymphatic 
vessel from rat tails. A representative image (z-stack) staining for smooth muscle actin (α-
SMA; Panel A), nuclear staining (DAPI; Panel B), and merged SMA and DAPI (Panel C) for 
valvular and tubular regions of a lymphatic vessel from rat tails. The 3D reconstruction of 
actin fibers of SMCs with nuclear staining (DAPI and SMA; Panel D) and with collagen fibers 
were obtained from SHG imaging (collagen and SMA; Panel E). The vessel was fixed and 
flatted on a glass slide. The images were taken from the same vessel and the imaging window 
dimensions and depth were about 300µm×300µm and ~10µm respectively. The images from 
different locations were stitched together to obtain an image of the first panel. 
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and valvular regions. Tubular region was defined as 100µm distance from the valve. A 
closer look at SMCs coverage in the tubular the region showed a heterogeneous structure 
of strips in the circumferential direction with sporadic longitudinal bundles connecting 
different fibers, whereas the valvular region was predominantly composed of thick bundles 
in the longitudinal direction. That it is possible that the alignment is more circumferential 
as one moves further away from the valve. The analysis of actin fibers and nuclei 
orientation confirmed that most cells, as well as actin and collagen fibers in the valvular 
region, were aligned in the axial direction, whereas the tubular region’s nuclei and actin 
fiber distributions are more heterogeneous (Fig. 2.6). The local maximum of nuclei and 
actin fiber orientations occurred in both axial and circumferential directions, but collagen 
fibers were predominantly oriented in the axial direction. 
 
Figure 2. 6 Analysis of nuclei (Panel A and B), and actin fiber (Panel C and D),  obtained for 
valvular and tubular regions. The histograms were plotted based on different z-stacks obtained from 
DAPI, α-SMA imaging in Fig. 2.4 (D & E). 
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Figure 2. 7 Results of the collagenase experiment for a single vessel treated with Collagenase Type 
II for 30 minutes. Both the diameter and length of the vessel increase after degradation of collagen 
fibers suggesting that collagen fibers contribute to constraining vessel dimensions.  
Effects of transmural pressure on lymphatic contractility. The amplitude of 
contraction decreased from 90.7µm to 29.9µm as the pressure increased from 2mmHg to 
6mmHg (Fig. 2.7A). Similarly, the ejection fraction decreased 67% (from 44.6% to 14.7%) 
as pressure increased from 2mmHg to 6mmHg (Fig. 2.7B, n=5).  In contrast, the frequency 
of contractions increased ~ 40% ( from ~7.4 min-1 to ~12.3 min-1) as the pressure increased 
from 2mmHg to 4mmHg; however, a further elevation of transmural pressure from 4mmHg 
to 6mmHg slightly increased frequency (~12.3 min-1 at 4mmHg to ~13.3 min-1 at 6mmHg, 
Fig. 2.7C). Consequently, the fractional pump flow increases from ~3.5 min-1 at 2mmHg 
to ~5.1 min at 4mmHg; however, an additional pressure increment (from 4mmHg to 
6mmHg ) resulted in ~ 47% reduction in pumping (~2.7 min-1 at 6mmHg, Fig (2.7D)). All 
functional experiments were performed at one axial stretch (~10%).  
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Figure 2. 8 Effect of transmural pressure on the contractile function of rat tail lymphatic vessels. 
The contractile metrics were plotted as a function of transmural pressure (n=5), including the 
amplitude of contractions (AMP; Panel A), frequency of contractions (FREQ; Panel B), ejection 
fraction (EF; Panel C), fractional pump flow (FPF; Panel D). The axial stretch was ~10% for all 
experiments. All data are presented as mean (±SEM) and statistical significance was tested via 
ANOVA with Tukey’s post-hoc tests (* p < 0.05, ** p < 0.005) 
2.1.4 Discussion 
Mechanical loading plays an important role in lymphatic contractile function.  
Lymphatic vessels adapt their contractile function to various loading conditions (pressure, 
flow, and external forces from skeletal muscles) which is important in their function both 
as a pump and as a conduit to efficiently transport lymph [40,85–88]. The effect of 
pressure-induced stretch on lymphatic contractile function has been well-documented 
[87,89–97]. These experiments demonstrated the existence of a length-tension relationship 
in lymphatic vessels from different regions through ex vivo experiments on isolated vessels 
[10,17,98,99]. Although there is heterogeneity in the contractile force generated from 
different regions, these studies suggest that muscle cells produce a maximum force in a 
wide range of pre-load (circumferential stretch) conditions [100].  
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Similar to circumferential stretch, axial stretch can also be a modulator of lymphatic 
function. In some regions, such as lung and diaphragm, the length of the vessel changes 
due to applied external forces. For example, pleural and diaphragm lymphatics can be 
exposed to cyclic stretches which enhance lymph formation and transport [101,102]. In 
this study, we showed that lymphatic vessels from rat tails are under axial pre-stretch in 
vivo. The isolated vessel experiments demonstrate that lymphatic vessels are sensitive to 
changes in the axial stretch. An axial stretch of 30% significantly decreased lymphatic 
contractions. To our knowledge, our study is the first to demonstrate the significance of 
axial stretch in the modulation of lymphatic contractility. We characterized the response of 
rat tail lymphatics to the axial stretch to shed light on the contractile force adaptation of 
lymphatic SMCs to axial stretch. Change in calcium influx is one possible mechanism 
through which stretch can modulate lymphatic contractility. Since lymphatic vessels are 
very sensitive to changes in extracellular Ca+2, e.g. too low a level or too high a level of 
Ca+2 ceases lymphatic contractions [92,103–105], the stretch might alter the extracellular 
calcium and thereby change the function of calcium channels such as voltage-gated L-type 
and T-type channels. There is also evidence that electrical activity of lymphatic vessels 
changes with the stretch. The higher stretch induces Ca+2 sensitization that increases the 
sensitivity of key contractile molecules to Ca+2 [106–108].  
Smooth muscle shape and orientation may contribute to axial contractility.  Another key 
factor that determines the effect of stretch is the shape and orientation of lymphatic SMCs. 
One study reports α-SMA positive cells (lymphatic SMCs) in rat diaphragm run 
longitudinally between intraluminal valves, but circumferentially in the valve regions 
[109]. Another study in guinea pig mesenteric lymphatics reports that some SMCs are 
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longitudinally orientated while others are orientated at approximately a 45° angle [110]. 
An investigation of lymphatic vessels in the diaphragm has suggested that active 
vessels showing rhythmic contractions have a dense mesh of actin fibers, but non-
contracting vessels have longitudinal actin fibers [111]. Another investigation of 
lymphatic muscle cells via F-actin staining in human thoracic ducts has suggested that non-
contracting thoracic vessels have an irregular organization of lymphatic SMCs and muscle 
bundles are heterogeneously oriented in the circular, oblique, and longitudinal directions 
[112]. Micrograph observation in monkeys has revealed cervical sections of the 
thoracic duct are less muscular compared to the abdominal and thoracic sections, 
suggesting the passive function of the cervical part [113]. As mentioned previously, it is 
believed that stretch modulates active contractions. Thus, axial stretch is also a candidate 
to alter active tension given the heterogeneous orientation of lymphatic SMCs. In the 
current study, immunostaining and imaging of fibers revealed the orientation SMCs are 
heterogeneous. In the tubular region, most fibers have circular orientation while some are 
longitudinally organized. In contrast, in the valvular region, most fibers have a longitudinal 
orientation. Analyzing the nucleus orientation of SMCs revealed a distribution similar to 
the actin fibers, suggesting that lymphatic SMCs are heterogeneously oriented. Thus, the 
axial stretch of SMCs may alter the active tension based on the orientation of lymphatic 
SMCs. 
Collagen fiber orientation may play a role in axial contractility.  In addition to the 
orientation and morphology of lymphatic SMCs, the organization of the extracellular 
matrix can influence lymphatic function. Particularly, collagen fibers play a key role in 
structural support and mechanics of lymphatic vessels. Currently, data on lymphatic vessel 
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wall mechanics and compositions are limited to a few measurements from rat thoracic duct, 
rat mesentery, and human pelvis [70,114,115]. Rat lymphatic vessels have been reported 
to be very distensible; a transition to a stiffer region occurs in response to an increase in 
transmural pressure [70]. It is thought that these vessels are very compliant in the 
physiological range (< 5 cm H2O) [115]. Observations from rat thoracic duct have shown 
the non-linear response and vessel stiffening occurs in response to both axial stretch and 
circumferential stretch [70]. It is believed that collagen, elastin, and SMCs are the main 
components that constitute the mechanical behavior of lymphatic vessels [70,114–116]. 
Collagen organization and fiber recruitment are important factors that not only determine 
the passive function but also influence the contractile function of lymphatic vessels. Recent 
multiphoton imaging of collagen fibers within the wall of the pelvic lymphatic vessel has 
shown that the fibers are predominately oriented in the axial direction [114]. Similar results 
were found for the bovine [116] and rat lymphatics, although there are some variations 
[70]. In the current study, we showed that collagen fibers are predominately oriented in the 
longitudinal direction, supporting our observation that the vessels experience pre-axial 
stretch in situ. Our results showed changing the transmural pressure from low to high 
pressure did not change the predominant orientation of collagen fibers in the longitudinal 
direction. The results suggest that vessels are under maintained longitudinal stretch in situ. 
The degradation of collagen fiber suggested that axial collagen contributes to constraining 
vessel dimensions. The other interesting finding is the sensitivity of vessels’ spontaneous 
contractions to the level of pre-axial stretch. The ex vivo results suggest that vessel 
contractility is tightly regulated by the stretch level. 
2.2 Milestone 2: 
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To characterize the effect of NO on lymphatic contractility via ex-vivo experiments on the 
isolated rat tail lymphatic vessels and administration of the exogenous NO. 
 Hypothesis II: Exogenous NO inhibits lymphatic contractility in a dose-response manner. 
2.2.1 Introduction 
The lymphatic system can adjust the contractile function in response to mechanical 
and biochemical stimuli. Mechanical stretch due to pressure is known to be a key modulator 
of lymphatic contractility (6–10). It is well documented that the frequency of contractions 
changes in response to pressure and the active tension changes with stretch for lymphatic 
vessels [122–124]. In addition, previous studies have demonstrated small molecules such 
as  nitric oxide (NO), histamine, and  endothelin-1 (ET-1) play key roles in the regulation 
of lymphatic contractility [4,125–129]. For example, the effects of endothelial-derived NO 
due to flow-shear sensation by lymphatic endothelium or NO production from iNOS-
expressing cells surrounding lymphatic vessels in inflammatory scenarios have been 
studied [42,125,130–132]. The effect of endothelial-derived NO on lymphatic contractility 
is also well documented via pharmacological inhibition and genetic deletion of eNOS 
[125,132]. There are some studies that investigate the effect of exogenously administrated 
NO on lymphatic contractility [133]. Yet, there is a pressing need for specific experimental 
data to develop computational models capturing the effect of exogenous NO on lymphatic 
contractility in a dose-dependent manner.   
2.2.2 Methods 
2.2.2.1 Vessel isolation.   
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Segments of collecting lymphatic vessels from male Sprague Dawley rats (300-350 
g) were isolated. Once isolated, vessels were immediately placed in Dulbecco’s Phosphate 
Buffered Saline (DPBS, Corning) and the surrounding fat and connective tissues were 
carefully removed. Once cleaned, vessels were mounted on opposing cannulae in a custom-
designed vessel chamber [75]. For the isolated vessel experiments, each vessel was 
harvested from a different animal. All animal protocols were reviewed and approved by 
Georgia Tech's Institutional Animal Care and Use Committee (IACUC). 
2.2.2.2 Study of Active Contractility and its Response to Nitric Oxide.  
After removing the surrounding fat and connective tissues, lymphatic vessels (containing 
approxiamtely1-2 valves) were mounted on opposing cannula in a custom-made vessel 
chamber. Once the vessels were preconditioned for ~ 1hr, four doses of SNP (10-7 , 10-6 , 
10-5 , 10-4) were administrated for 5 minutes at each dose. To quantify contractility response 
of lymphatic vessels, we used a custom-written LabView program to analyze images 
recorded during the protocol. Once data was analyzed, end-systolic diameter (ESD), end-
diastolic diameter (EDD), and contractions frequency (FREQ) were calculated. 
Subsequently, several metrics of lymphatic pumping were calculated including amplitude 
(AMP), ejection fraction (EF), fractional pump flow (FPF), as defined previously. Data 
obtained from the stretch-pressure protocol were plotted as a function of stretch and 
pressure respectively. Additionally, to determine changes in the contractile response of 
lymphatic vessels to doses of SNP , changes in the contracile parameters and a change in 
lymphatic tone (Tone) were calculated as follows: 
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Change in Tone= (EDD-EDDcontrol)/EDDcalcium-free (4) 
Change in AMP=(AMP-AMPcontrol)/ AMPcontrol (5) 
Change in EF=(EF-EFcontrol)/ EFcontrol (6) 
Change in FPF=(FPF- FPFcontrol)/ FPFcontrol (7) 
EDDcalcium-free indicates the end-diastolic diameter in calcium-free state at the same 
pressure. The subscript “control” represents the parameters before administration of SNP 
doses.  
2.2.2.3 Statistics. 
 To determine the statistical significance between control and experimental groups, a one-
way ANOVA in conjunction with Tukey’s post hoc correction was used to make multiple 
comparisons. Prism 5 (GraphPad Software) was used to perform all statistical analyses 
with significance set at p < 0.05 and results were reported as means (±SEM).  
2.2.3 Results 
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Figure 2. 9 Effect of exogenous NO via SNP administration on contractile function of isolated 
vessels from rat tail. A representative of diameter tracing from an isolated vessel experiment where 
different doses of SNP were administrated (Panel A). The change in contractile parameters were 
plotted as a function of SNP doses, including change in basal tone (Tone; Panel B), frequency of 
contractions (FREQ; Panel B), ejection fraction (EF; Panel C), fractional pump flow (FPF; Panel 
D). The pressure was set to 3mmHg and the axial stretch was ~10% for all experiments. All data 
are presented as mean ±SEM (n=4) and statistical significance was tested via ANOVA with 
Tukey’s post-hoc tests (* p < 0.05) 
 
Figure 2. 10 Percent change in contractile metrics (from Fig.2.8) in response to different SNP doses 
including percent change in end-diastolic diameter (AMP; Panel A), percent change in basal tone 
(Tone; Panel B), percent change in frequency of contractions (FREQ; Panel C), percent change in 
amplitude of contractions (AMP; Panel D) percent change in ejection fraction (EF; Panel E), 
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percent change in fractional pump flow (FPF; Panel F). All data are presented as mean ± SEM 
(n=4) and statistical significance was tested via ANOVA and Tukey’s post-hoc tests (* p < 0.05, 
** p < 0.005, etc). The statistical significances were tested to compare changes with respect to 
control values (SNP dose=o) as well multiple comparison between different doses.   
Exogenous NO inhibits lymphatic contractility in a dose-dependent manner. 
A representative isolated lymphatic vessel from rat tail  along with respective diameter 
tracing in response to the administration of SNP doses to the bath is shown in Fig. 2.8. The 
contractile activity of the isolated vessels in response to the administration of SNP doses 
was quantified  (Fig. 4 , n=4). The lymphatic tone decreased by 36.6% (from 6.8% to 4.6%) 
equivalent to ~8um increase in the diastolic diameter (Figs. 2.8B 2.9B). The frequency of 
contractions significantly decreased almost 60% (from ~11.6 min-1 to ~4.5 min-1) at the 
highest dose; however, the maximum reduction occurred from 10-7 (M) to 10-8 (M), (Figs. 
2.8 and 2.9C). Similar trends were observed for the ejection fraction and amplitude of 
contraction, however, the maximum reduction was around 30%. The ejection fraction 
decreased 31.4% (from 0.52 to 0.36) at the maximum dose respectively (Fig. 2.8D-E and 
2.9D-E) . Consequently, the fractional pump flow decreased  with increase in the SNP 
concentration up to ~70% (Fig. 2.8F and 2.9F). All experiments were performed at constant 
pressure (~3mmHg) and one axial stretch (~10%).  
2.2.4 Discussion 
The strong pumping capability of rat tail lymphatic vessels. The effect of the 
transmural pressure on the modulation of lymphatic contractility has been very well-
documented. Gashev et al. [134] have previously characterized the regional heterogeneity 
of contractility in the rat mesentery, rat thoracic duct, rat neck, and rat hindlimb lymphatics. 
In the rat mesentery, rat neck, rat hindlimb the frequency continuously increases with the 
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incrementally increase in the pressure, while the rat thoracic duct shows a peak in the mid-
pressure range and the frequency decreases for the higher pressures. The rat neck lymphatic 
vessels have the highest frequencies while the thoracic duct has the smallest frequency. In 
contrast, the rat mesentery and rat thoracic duct have the highest ejection fraction while the 
rat neck has the smallest ejection fraction values. Consequently, the rat mesentery has the 
highest values of fractional pump flow, the thoracic duct has the lowest values, while the 
rat neck and hindlimb have comparable values. Further, a peak is observed in the fractional 
pump flow for all the lymphatic vessel from all regions. Our characterization of rat tail 
lymphatic contractility, suggests that the values of the frequency response are similar to 
those of the rat mesentery; however, the ejection fractions are slightly smaller and are 
closer to those of thoracic duct. Ultimately, the fractional pump flow from the rat tail that 
represents the overall pumping is similar to the rat mesentery. The regional heterogeneity 
in lymphatic function suggests that some vessels mainly serve as a pump (e.g., mesenteric 
lymphatics) where a high pumping capacity is needed, and some mainly function as a 
conduit (e.g., thoracic duct) where the minimal pumping is required [17,134]. This idea is 
also supported by the shear-flow sensitivity response in lymphatic vessels, where a 
significant shear-inhibition is observed in the lymphatic vessels from rat thoracic duct 
[135,136]. Our results suggest that the collecting lymphatic vessels from the rat tail exhibit 
strong pumping capability similar to the rat mesentery. Functionally, the rat tail lymphatics 
are afferent (pre-nodal), where there is no lymph node upstream to the vessels. Hence, the 
strong contractility can be justified by their major pumping role in the tail tissue.  
The physiological importance of NO and its inhibitory effect on lymphatic 
function. The nitric oxide (NO) is believed to be a key regulator in the modulation of 
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lymphatic contractile function [97,137–141]. There are several sources of NO in lymphatic 
systems including 1) production of NO via LECs (eNOS pathway) due to shear stress 2) 
production of NO via inducible NO synthase (iNOS pathway) in immune cells or lymphatic 
SMCs surrounding lymphatics 3) production via nerve tissues (nNOS pathway) in 
perivascular tissues [79,125,139,142,143]. The mechanism of NO action is believed to be 
through the cGMP pathway that leads to the relaxation of muscle cells [144–149]. Based 
on immunohistochemical studies and microelectrode measurement of NO, it has been 
suggested that NO is produced in response to flow in both valvular and tubular region of a 
lymphangion [4,131,150]. There is evidence that contractile metrics such as amplitude and 
frequency of contractions attenuate in response to NO synthesis due to imposed flow 
[9,97]. Similarly, inhibition of NO synthase has shown that contractions enhance under the 
basal conditions and that the inhibitory effect of imposed flow on contractions is inhibited 
[125,151,152]. It is widely accepted that the effect of NO can be context-specific. For 
example, high concentration of NO is believed to suppress amplitude and frequency of 
contractions; however, low concentration of NO is thought to enhance contractions by 
increasing amplitude at the expense of frequency reduction [4,125,131,132,141,142,153]. 
In contrast, comparing the in-situ measurements of lymphatic function in NO-deficient 
(eNOS−/− ) mouse, to the temporary inhibition of NO synthesis (via blockers infusion) have 
shown that diastolic diameter decreases but overall pump function is maintained [143]. As 
mentioned earlier, inducible NO (via iNOS) can be another significant source of NO; 
however, the studies in this area in the context of lymphatics are very limited [143]. It has 
been shown that NO released by endothelium with acetylcholine (ACh) stimulation inhibits 
spontaneous contractions of lymphatic vessels.  
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Sodium nitroprusside (SNP) is one of the most studied nitric oxide (NO) donors. It 
is believed that the capability of SNP to produce NO depends on its interaction with 
sulfhydryl-containing molecules available in-vivo [154]. Hence, we used sodium 
nitroprusside (SNP) to deliver exogenous NO to isolated lymphatic vessels at different 
doses. Our findings support the idea that NO effect is dose-dependent and the 
administration of higher doses of NO can suppress all aspects of contractility. Our 
experimental findings show exogenous NO has an inhibitory effect on lymphatic 
contractions; however, there is a dose response and higher doses of NO cannot completely 
abolish contractions. Interestingly, we showed that exogenous NO decreased the amplitude 
of contractions; however, the predominant effect was on the frequency of contractions. 
Further, we showed that exogenous NO reduced pumping up to 70% but it is not able to 
completely abolish contractions. The reduction in contraction frequency is almost twice 
the reduction in tone and amplitude. The results suggest the exogenous NO diminishes 
pacemaking activity in line with the established effect of SNP on the reduction of 
spontaneous transient depolarizations (STDs) frequency and amplitude in lymphatic SMCs 
[140,155].  The findings also suggest that overproduction of NO production beyond the 
physiological range, (e.g., NO production from iNOS-expressing cells located surrounding 
lymphatic vessels in inflammatory scenarios [156]) can inhibit lymphatic contractions, a 
possible mechanism that may lead to the lymphatic dysfunction in pathological scenarios. 
2.2.5 Conclusions 
In conclusion, the current study demonstrates the significance of the axial pre-
stretch and exogenous NO in lymphatic contractile function and provides new insights into 
the physiological function of collecting lymphatic vessels. These findings suggest the rat 
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tail may serve as a useful animal model to test new hypotheses regarding lymphatic health 
and disease.  
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CHAPTER 3. A MICROSTRUCTURALLY MOTIVATED 
CHEMO-BIOMECHANICAL FRAMEWORK FOR LYMPHATIC 
VESSELS 
3.1 Aim 2 
To establish a microstructurally motivated chemo-biomechanical framework 
based on the experimental observations in Aim1, to model passive and active responses of 
rat tail lymphatic vessels to mechanical/biochemical perturbation (axial stretch and 
nitric oxide). There are three milestones for Aim 2 as follows: 
3.2 Milestones 1&2:  
Milestone 1:  
To determine the material parameters that describe the passive constituents of rat tail 
lymphatics and the variance of these parameters using a microstructurally-motivated model 
and a bootstrapping technique. 
Hypothesis I:  We test our hypothesis that a three-fiber family constitutive model 
including one axial and two symmetric diagonal family of fibers along with a bootstrap 
technique provides a reliable technique to fit lymphatic multi-axial data and to determine 
material properties and their respective confidence intervals. 
Milestone 2:  
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To develop a computational framework to model the effect of exogenous NO and axial 
stretch on lymphatic contractility. 
 
Hypothesis II:   
Changes in lymphatic contractility due to axial stretch and NO administration can be 
modeled via the effects of NO on force production by lymphatic muscle cells and the 
effects of axial loading on circumferential stretch and length-tension relationships 
describing lymphatic force production in the circumferential direction.   
 
3.2.1 Introduction 
The lymphatic system is composed of a hierarchical network of lymphatic vessels working 
in parallel to the circulatory system to transport lymph from the interstitial space back to 
the great veins [18]. The lymphatic network plays a key role in maintaining tissues 
hemostasis, transport of macromolecules, dietary fat and serves as a route for immune cell 
surveillance [157]. Once lymph is formed, the network of lymphatic capillaries (initial 
lymphatics) absorb lymph and ultimately converge to collecting lymphatic vessels that 
unidirectionally transport lymph back to the great veins [18,79]. The primary lymphatic 
valve prevents the leakage of absorbed lymph back to the interstitium due to prevailing 
pressure gradients across the valve [118]. Collecting lymphatic vessels (lymphangions) 
actively transport lymph via a series of orchestrated contractions.The collecting lymphatic 
vessels are covered by specialized lymphatic smooth muscle cells that enable the vessels 
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to propel lymph against an adverse pressure gradient from the interstitium to the great vein 
[158]. The secondary lymphatic valves separate these collecting ducts to ensure 
unidirectional flow and to break the hydrostatic pressure [118].  
The lymphatic system can adjust the contractile function in response to mechanical 
and biochemical stimuli. Mechanical stretch due to pressure is known to be a key modulator 
of lymphatic contractility. It is well documented that the frequency of contractions changes 
in response to pressure and the active tension changes with stretch for lymphatic vessels 
[122–124]. In addition, previous studies have demonstrated small molecules such as  nitric 
oxide (NO), histamine, and  endothelin-1 (ET-1) play key roles in the regulation of 
lymphatic contractility [4,125–129]. For example, the effects of endothelial-derived NO 
and  NO production from iNOS-expressing cells have been studied [42,125,130–132]. The 
effect of endothelial-derived NO on the lymphatic contractility is also well documented via 
pharmacological inhibition and genetic deletion of eNOS pathway [125,132]. 
In addition to ex-vivo and in-vivo studies of lymphatic pumping, computational 
modeling has emerged as a useful tool to shed light on the salient features of lymphatic  
function. Several groups have developed models to study lymphatic pumping based on the 
mathematical models and experimental observations for collecting lymphatic vessels 
[60,61,70,71,62–69]. These computational models have been used to provide insight into 
lymphatic pumping in the context of the optimal working condition; however, most of these 
studies are based on a single experimental observation in an ex-vivo or in-vivo study and 
conflicting results have been reported [72,73]. Caulk et al developed a computational 
framework to constitutively model the passive and active mechanics of lymphatic vessels 
based on the hyperelasticity theory and ex-vivo experiments [70]. This framework was 
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successfully used to fit experimental data from rat thoracic duct. Further, an algorithm was 
developed to use this framework coupled with a valve model to perform parametric studies 
of lymphatic adaptation to different loading conditions [71,74]. 
 Given the complexity and regional heterogeneity of the lymphatic system, the 
regional specificity of experimental data (e.g., contractile and biomechanical data) is 
crucial to develop reliable models. There is still a pressing need to provide a validated 
model capturing both biomechanical and biochemical function of lymphatic vessels based 
on the regional specific data; specifically, experimental data on the dose-dependent effect 
of exogenous NO on the lymphatic contractions has yet to be incorporated into 
computational models. This section characterizes the passive biomechanical properties and 
active contractile function of the rat tail lymphatic vessels in response to transmural 
pressure and the exogenous NO, and ultimately provides a validated constitutive 
framework to recapitulate the experimental observations. 
3.2.2 Methods 
Study of Passive Biomechanical Properties. We used an improved biaxial device 
that precisely controls transmural pressure, diameter, and axial stretch [81]. A custom 
LabVIEW program was developed to control transmural pressure via a syringe pump 
(Harvard) and pressure sensors (1psi SSC series, Honeywell). Linear actuators and XYZ 
stages (Newport Precision, LTA series and M-461 series) were used to precisely control 
axial stretch. Using an inverted microscope (2.5x magnification) and a digital camera 
(Allied Vision Technologies, Marlin F-033B), the active and passive response of vessels 
to different transmural pressures and axial stretches were captured and save for further 
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analysis. Axial forces were measured using a 50mN force transducer (Aurora Scientific, 
Model 400A). Vessels were given ~45-60 min to equilibrate at DMEM/F-12   (Dulbecco's 
Modified Eagle Medium/Nutrient Mixture F-12 plus Pen-Strep 1:100, pH=7.4 at 37℃) to 
establish stable contractions. For passive biaxial testing, the solution was changed to Ca2+-
free PBS solution (Corning® Phosphate-Buffered Saline, 1X without calcium and 
magnesium, PH 7.4 ± 0.1) containing 3mM EDTA [70,159]. All vessels were 
preconditioned by ramping the transmural pressure from 0 to 10 mmHg while at three 
stretch steps of 10%, 20%, and 30%. A pilot study was used to determine the range of 
pressure and stretch values for the testing protocols. The pressure-diameter and force-
pressure responses at these values resemble the physiological biaxial response of vessels.  
Thickness measurement. An inverted microscope (Objective 2.5x) equipped with 
a camera (Allied Vision Technologies, Marlin F-033B)  was used to acquire images of 
vessels. The vessels were pressurized at ~0.5mmHg and axial stretch was set to one. Images 
were analyzed using ImageJ software to calculate thickness. The thickness was calculated 
based on the measurement of internal and external diameters.  
Constitutive Modeling. To capture salient features of lymphatic vessel mechanics 
(e.g., structural stiffness) and to reveal their contribution to lymphatic contractility, we 
employ a two-dimensional constitutive framework to fit experimental data obtained from 
the biaxial testing. The mechanical stress within the wall of a lymphatic vessel originates 
from passive elasticity and active force production by lymphatic smooth muscle cells, 
namely: 
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𝜎 = 𝜎𝑝𝑎𝑠 + 𝜎𝑎𝑐𝑡 (1) 
 
where 𝜎  is totall mechanical stress response, 𝜎𝑝𝑎𝑠  is the passive component of stress 
resulting from vessel’s elasticity and 𝜎𝑎𝑐𝑡  is the active component exerted by smooth 
muscle cells. Based on the two-dimensional equiblirium equations for a straight and 










where 𝜎𝜃, and 𝜎𝑧 are circumferential and axial stresses respectively; P is the transmural 
pressure; r is the luminal radius; h is the wall thickness; f is the applied axial force. Based 
on hyper-elasticity theory, the passive stress tensor can be approximated using the Cauchy 
stress as: 




where F is the deformation gradient tensor; W is a scalar function representing the stored 
energy density for elastic deformations. The deformation gradient components (𝐹 =
𝑑𝑖𝑎𝑔(𝜆𝑟 , 𝜆𝜃, 𝜆𝑍), 𝑤ℎ𝑒𝑟𝑒 𝜆𝑟 = ℎ 𝐻⁄ , 𝜆𝜃 = 𝑟 𝑅⁄ , 𝜆𝑧 = 𝑙 𝐿⁄  and (h, r, l) and (H, R, L) are 
thickness, radius and length for the loaded and unloaded vessel respectively) represent 
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circumferential and longitudinal stretches respectively. Motivated by the recent 
observation of collagen organization in the rat tail lymphatic vessels, where the collagen 
fibers are normally distributed with a peak in the axial direction, we chose a three-family 
stored energy function as: 










𝑖  and 𝑏2
𝑖  are material parameters, 𝐼𝐶  is the first invariant of the right Cauchy-





 is the stretch of the ith fiber 
family (𝜆𝑖 = 𝐶𝜃𝜃𝑠𝑖𝑛
2(𝛼𝑖) + 𝐶𝑧𝑧𝑐𝑜𝑠
2(𝛼𝑖)), where 𝛼𝑖  is the fiber angle (please see Ref. 
([160])  for details). We tested different number of family fibers (e.g., 2, 3, and 4 ) and a 
3-fiber model (one longitudinal and two symmetric diagonal family of fibers) was found 
to best capture the data. 
To model the active contractile force generated by lymphatic smooth muscle cells, we 
modified a model proposed by Caulk et al. [161] to incorporate the effect of SNP doses on 
the contractile force generation, namely: 
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where 𝑇𝑎𝑐𝑡  is a scaling parameter, 𝜆𝜃  is the circumferential stretch, 𝜆𝑀  and 𝜆0 are the 
stretches at which the active force is maximum and minimum respectively. The parameres 
𝜆𝑀 and 𝜆0  were prescribed as the maximum stretch achieved during the passive testing 
(𝜆𝑀 =1.85) and the minum circumferential stretch (𝜆0 =0.85) during the active testing.  
As shown by Caulk et al. [70], 𝑇𝑎𝑐𝑡 is a function of pressure that is minimum at diastole 
(Tdia = Tact,min = 𝑓(P) = a ∗ P) and becomes maximum at systole (Tsys = Tact,max =
Tact,min + a ∗ P ) .  Parameter b is the maximum due to SNP dose, IC50 (inhibitory 
concentration, 50%) is the dose value where the dose response is half maximal value. 
Bootstrapping and Parameter Estimation. Since the lymphatic system shows 
regional heterogeneity it is crucial to have a robust parameter estimation to identify 
biomechanical properties and their confidence intervals [100,134]. To determine best-fit 
parameters, a nonlinear regression using function lsqnonlin in MATLAB 2015b 





















where th indicates a theoretical value and exp denotes an experimental value, 𝜎𝜃
𝑡 , 𝜎𝑧 are 
circumferential and axial stress respectively, and overbar indicates the mean value. Since 
the objective function is the residual sum of squares to the total sum of squares, the 
cofficient of determination with each specimen are present as R2 =1-error. This means 
minimizing the error function results in maximizing the R-squared (R2) value. It should be 
noted that different groups have defined different error functions [162], however, we 
 47 
experimented with different objective functions and the above objective function provided 
better fits both visually and quantitavely. 
We also used a non-parametric bootstrapping technique to estimate the confidence 
interval of nonlinear regression as well as the uniqueness of nonlinear regression. The 
details of the bootstrap technique for parameter estimation can be found in ref. [163–165]. 
In brief, to apply the bootstrap technique to biaxial data, a resampling with replacement is 
used to generate bootstrap replicants that have the same number of observations as the 
original data set while each data has the same probability to be chosen and thus each data 
point may be included more than one time. To estimate 95% bootstrap confidence intervals, 
we used the Bias-corrected and accelerated percentile method (the BCa intervals) which is 
a second-order accurate interval that corrects for bias and skewness of bootstrap estimates. 
The number of bootstrap replicants above 1,000 typically provides an accurate estimate. 
The function bootci in (MathWorks, Inc) with 2,000 bootstrap samples was used to 
calculate the respective confidence intervals of parameters in nonlinear regression. The 
mathematical details of the BCa correction can be found in [166,167].  
3.2.3 Results 
Quantification of passive and active biomechanical properties. The three-fiber 
family constitutive model yielded a good-fit (R2=0.90±0.03) for the rat tail lymphatic 
vessels (Figure 3.1, Table 3.1). Supporting the previous experimental observation, our 
modeling results indicate that a three-fiber family model was sufficient to provide a good 
fit of biaxial data [168]. Based on the estimated parameters, the axial collagen fiber family 
(𝐶1
1= 2.05±1.76 (kPa), 𝐶2
1=1.2×10-3±1.0×10-3 (kPa))  and two symmetric diagonal fiber 
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families ( 𝐶1
2 = 1.21±0.82 (kPa), 𝐶2
2 =1.5×10-3±6.7×10-4 (kPa), and 𝛼 =31.6º±4.9º) 
significantly contribute to the load bearing function of lymphatic vessels; however, the 
amorphous matrix had a much smaller contribution (𝐶=5.4×10-7±4.4×10-8 (kPa)).  This 
suggest the longitudinal and diagonal fibers show a comparable contribution to the load 
bearing function; however, the amorphous matrix has a smaller contribution (Fig. 3.2A). 
The mentioned values are based on the average values of best fits for parameter estimation 
and the avarage of bootstrapping values for the respective confidense intervals (Fig. 3.2A 
and Table 3.1). In addition, a representative estimation of respective confidence intervals 
using bootstrapping via 2,000 bootstrapping is shown in Fig. 3.2B. Note that we also 
considered a four-fiber family model, following previous studies ref. [75,160,169]), 
allowing an additional family of collagen fibers beyond the axial and diagonal collagen 
families (e.g., circumferential collagen). However this does not improve the descriptive 
capability of the constitutive model (results not shown).  
Table 3. 1 Passive material parameters estimations respective confidence intervals for rat tail 
lymphatic vessels using a three-fiber family constitutive model. The objective function for the 
optimization was defined as Error=1- R2 value, calculated based on the biaxial data and estimated 
parameters. The best fit values along with the bootstrapped confidence intervals are presented for 
each specimen. The estimated parameters and associated R2-values exhibit consistency indicating 




Figure 3. 1 A representative plot of experimental biaxial testing and respective fitting results using 
a three-fiber family constitutive model including pressure-diameter measurements at different axial 
stretches and their respective theoretical values (Panel A), axial force-pressure measurements at 
different axial stretches and their respective theoretical values (Panel A), the stored strain energy 
was calculated based on the estimated parameters from sample 1 (Panel C) and a 2-D iso-contour 
representation of strain energy as a functional of circumferential and axial stretches (Panel D).    The 
plus symbols indicate experimental data and solid lines denote theoretical values based on the best 
fit values (sample 1 in Table 3.1). 
Specimen Elastic Fiber          Axial Collagen              Diagonal Collagen                
1 best fit 5.02E-07 4.94E+00 5.78E-04 1.90E+00 5.93E-04 25.28 0.9258
BCa interval 5.00E-07 2.93E+00 4.27E-04 1.71E+00 5.43E-04 25.04
6.27E-07 7.71E+00 7.44E-04 2.60E+00 6.23E-04 25.73
2 best fit 6.03E-07 1.69E+00 1.15E-03 3.14E-01 1.99E-03 31.14 0.9184
BCa interval 5.31E-07 1.20E+00 7.11E-04 1.96E-01 1.87E-03 30.948
9.95E-07 7.50E+00 1.25E-03 4.06E-01 2.16E-03 31.31
3 best fit 5.66E-07 1.74E+00 8.30E-04 1.50E+00 2.12E-03 34.87 0.8768
BCa interval 3.75E-07 1.23E-01 1.92E-04 1.15E-01 3.29E-10 34.44
9.31E-07 1.62E+01 1.89E-03 8.94E+00 4.70E-03 66.68
4 best fit 5.41E-07 1.78E+00 4.67E-04 3.67E-01 1.95E-03 37.92 0.9116
BCa interval 5.10E-07 1.13E+00 3.29E-04 2.91E-01 1.85E-03 37.73
7.78E-07 2.32E+00 5.71E-04 4.12E-01 2.03E-03 38.03
5 best fit 5.00E-07 1.18E-01 2.99E-03 1.98E+00 1.10E-03 28.95 0.8605
BCa interval 4.69E-07 1.71E-12 1.30E-03 9.40E-02 2.67E-04 28.95
1.00E-06 2.49E+00 1.56E-02 4.46E+00 2.68E-03 28.95
Average 5.43E-07 2.05E+00 1.20E-03 1.21E+00 1.55E-03 31.63 0.8986
SE 4.41E-08 1.76E+00 1.03E-03 8.17E-01 6.70E-04 4.94 0.0284
 𝑐( 𝑃𝑎) 𝑐1
1 ( 𝑃𝑎) 𝑐2
1 ( 𝑃𝑎) 𝑐1
2  ( 𝑃𝑎) 𝑐2
2  ( 𝑃𝑎) 𝛼(𝑑𝑒𝑔𝑟𝑒𝑒) 𝑅
2
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Table 3. 2 Structural parameters associated with the unloaded geometry for rat tail lymphatic 
vessels presented in Table 1. The diameter, thickness, and length were estimated based on images 




Figure 3. 2 Material properties based on the fitted experimental biaxial data using a three-fiber 
constitutive model for rat tail lymphatic vessels (n=5) including best-fit values of model parameters 
for five samples (Panel A), and a representative estimation of respective confidence intervals using 
bootstrap technique showing the results of 2,000 bootstrapping along with the best fit-values (blue 
line) and the BCa confidence intervals for each parameter (red dashed lines) based on the specimen 
1 in Table 1 (Panel B).  
Specimen Length (mm) Diameter (µm) Thickness (µm) Thickness/Diameter Ratio
1 2.76 252 19 0.08
2 3.40 231 11 0.05
3 2.64 252 25 0.10
4 2.65 315 24 0.08
5 2.03 206 20 0.10
Average 2.70 251.20 19.89 0.08
SE 0.48 40.38 5.55 0.02
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Figure 3. 3 Modeling active contractile function of rat tail lymphatics based on the passive 
biomechanical data and active contractile data.  The pressure-diameter curves for passive behavior 
including passive, diastolic and systolic curves were plotted for three different values of axial 
stretch (Panel A) and fitting results of contraction frequency in response to the transmural pressure 
(Panel B). The passive parameters were obtained based on the constitutive model (Eqs. (8-12)) 
using the fitted parameters from sample 1 in Table 1, and active diastolic and systolic curves were 
computed based on the active-tension model, Eq. (6) where parameter Tact was determined to be 
Tsys= Tdia + 1.6498 (kPa) at systole and Tdia=0.87*P(mmHg) at diastole,  estimated based on an 
algorithm to fit the contractile data for three pressures of 2, 4, and 6 mmHg at 10% stretch in Fig.2 
7. An exponential equation using nonlinear regression ( FREQ= 15.51*(1-exp(-0.3493*Pressure), 
R2=0.52) was used to fit experimental data. The pressure-diameter curves for passive behavior 
including passive, diastolic and systolic curves were plotted for three different values of axial 
stretch (Panel C) and the respective computed total circumferential stresses were plotted as a 
function of circumferential and axial stretches (Panel D). 
Constitutive modeling of active contractile function and its response to NO.  
As shown by Caulk et al [75], diastolic tension increase with increased pressure and hence 
a the diastolic 𝑇𝑎𝑐𝑡 is a function of pressure. We used the average tone (Tone=7.6% at 
3mmHg, Fig. 2.8B) to fit the linear relation between the diastolic 𝑇𝑎𝑐𝑡 and transmural 
pressure (𝑇𝑑𝑖𝑎 = 0.87 ∗ P(mmHg) (kPa)). Similarly, the average ejection fractions 
(44.6% at 2mmHg,  34% at 4mmHg, 14.7% at 6mmHg, Fig. 2.7C) were used to obtain 
systolic 𝑇𝑎𝑐𝑡 (𝑇𝑠𝑦𝑠 = 0.87 ∗ P(mmHg)  +  1.6498 (kPa)). Modeling results including 
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systolic, diastolic and passive diameter-pressure curves along with respective experimental 
data are shown in Fig. 3.3A. In addition, a nonlinear regression (FREQ(min − 1) =
 15.51 ∗ (1 − exp(−0.3493 ∗ P(mmHg)), R2 = 0.53) was used to fit the frequency data 
(Fig.3.3B). In addition, modeling results at different axial stretches were shown in 
Fig.3.3C. Pressure-diameter curves showed that an increase in the axial stretch from 10% 
to 30% results in the reduction of systolic diameter and consequently the ejection fraction 
decreases from ~45% to less than 1% (Fig. 3.3C). Further, respective stress-strain curves 
showed the total circumferential stress decreased with increased axial stretch (Fig. 3.3D). 
Similarly, to model the effect of SNP on active stress, changes in contractile data due to 
SNP doses (Fig. 2.8B and D) were used to fit a dose-response curve (Fig. 3.4A). The 
correction parameter (C(SNP)) was calculated at each dose and finally, nonlinear 
regression was used to fit a dose-response curve 
(C(SNP)=0.80+0.2/(1+10^(log(SP)+6.42)), R2=0.98). The results suggest that the half 
maximal effective concentration is~ 10-6 (M) and approximately 20% change in active 
stress results in a ~30% reduction in diastolic and systolic diameters (Fig. 3.4B). 
Parametric simulations of the effect of axial stretch and SNP on lymphngion 
contractions.  The constitutive model was incorporated into a previously developed 
algorithm of lymphangion contraction. The details can be found in Caulk et al [71]. Matlab 
codes are provided in the Appendix as well. Parametric simulations predict that an increase 
in the axial stretch results in a decline in amplitude of contractions, pressure and lymphatic 
flow (Fig. 3.5 A-D). This prediction is supported by our experimental observation that axial 
stretch decreases lymphatic contractility. Interestingly, computational simulation predicts 
that an axial stretch equal to 30% significantly decreases the amplitude of contractions 
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which is line with experimental observations. Similarly, the modified constitutive 
framework was used to model the effect of SNP at a dose of 10-4 on contractions (Fig. 3.6 
A-D). Pressure-volume and flow-time curves show that flow significantly decreases after 
SNP administration. 
 
Figure 3. 4 Modeling the effect of SNP on the active contractile behavior of rat tail lymphatic 
vessels. A dose-response curve using a dose-dependent equation fits the correction factor (Eq. (13)) 
modeling the decrease in active contractile stress C(SNP)=0.80+0.2/(1+10^(log(SP)+6.42)), 
R2=0.98) due to SNP administration (Panel A).  Modeling results show the maximal changes in 




Figure 3. 5 Parametric simulations for a contracting lymphangion using the constitutive modeling. 
Simulation results show amplitude (Panel A), flow (Panel B), pressure (Panel C) and ejected 
volume (Panel D) decreases with the increase in axial stretch. 
 
 
Figure 3. 6 Modeling the effect of SNP on a contracting lymphangion. Amplitude and frequency 
of contractions decrease with SNP (Panel A) and flow and pressure, and ejected volume decrease 





Passive mechanics of lymphatic vessels and its contribution to lymphatic 
transport. It is essential to develop a basic knowledge of lymphatic vessel mechanics to 
have a better understanding of lymphatic transport in the context of lymphatic physiology 
and pathophysiology. Some efforts have been made to study the role of passive mechanics 
of lymphatic vessels for elucidating the modes of lymphatic regulations [75,114,115,120]. 
Ohhashi et al. [120] have shown that lymphatic vessels from the bovine mesentery manifest 
a nonlinear relationship between pressure and diameter, being very distensible at lower 
pressures and less distensible at larger pressures. More recent studies report similar 
findings in the rat mesentery [115], rat thoracic duct [75], and human pelvic vessels [114]. 
Based on the passive pressure-diameter relationship in the rat mesentery, the normal 
operating pressure is estimated to be between 0 to 5cm H2O, a range in which the vessel is 
very  distensible [115]. Caulk et al. performed biaxial testing on the lymphatic vessel from 
rat thoracic duct and shown that the nonlinear transitional response is a function of the axial 
stretch and pressure [75]. They show that at the lower axial stretch the transition occurs at 
low pressures (<5cm H2O); however, the pressure-diameter relationship in rat thoracic 
lymphatic vessels transitions to a linear shape at the axial stretch above 60%. Similar trends 
are observed for the human pelvic lymphatic vessels with some variations [114]. Our 
biaxial characterization of passive biomechanical properties of rat tail lymphatic vessel is 
qualitatively similar to those of rat mesentery and thoracic duct; however, the rat tail 
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lymphatic vessels are very sensitive to the level of the axial stretch and for the values above 
30%, the vessel becomes stiff and doesn't noticeably change the passive diameter over 
physiological ranges of transmural pressure. The axial forces in the rat tail lymphatic vessel 
can reach ~1mN at 25% stretch (p=10mmHg)  comparing to ~1mN at 50% stretch 
(p=10mmHg) for the rat thoracic duct [75].  Similarly, the human pelvic lymphatic vessel 
is very sensitive to the axial stretch ( ~1mN  at 20% stretch versus ~ 4mN at 30% stretch, 
p=5 cm H2O) [114].  
We fit the passive biaxial data using a fiber-family constitutive framework, 
originally adapted from Baek et.al and Caulk et. al [75,169], but adapted to including one 
axial and two symmetrical parallel collagen fiber families, as well as one component for 
amorphous matrix contribution. In addition, the estimated parameters for the axial and 
diagonal collagen fibers implies the axial fiber family plays a significant role in the load-
bearing function. The significance of axial stretch in passive behavior of lymphatic vessels 
is in agreement with our recent quantification of collagen fiber orientation in the rat tail 
lymphatic, where the vessels have a predominant organization of collagen fibers in the 
axial direction and experience the axial prestretch ~20% in-situ [168].  
Further, bootstrapping was used to obtain the confidence intervals of estimated 
parameters. Our approach for parameter estimation suggests that a three-fiber family along 
bootstrapping technique can be used to estimate intra-specific biomechanical parameters. 
Particularly, this is important because the variability in lymphatic properties is not 
uncommon. The variability in the estimated parameters from different rat tail lymphatic 
vessels have smaller variations and represent a predictive improvement comparing to those 
computed by Caulk et al [75], which had variations that ranged…. Previously, the 
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constitutive approach along with bootstrapping has been successfully used to determine 
changes in the biomechanical properties in the context of vascular remodeling in aging, 
and aneurysm [163,165]. Our results suggest that a three-fiber family along with the 
bootstrapping technique can be a useful tool not only to establish a descriptive framework 
to study the regional heterogeneity in the material properties of lymphatic vessels but also 
to study changes in those properties in the pathological scenarios. 
The rat tail as a novel lymphatic system to study NO effect on lymphatic 
contractions. Modeling approaches have been used to investigate the regulatory 
mechanism of NO on lymphatic contractility [72]. Kunert et al [72] presented a model 
describing two complementary feedback mechanisms to modulate lymphatic contractions 
involving: (i) a contraction triggered by Ca+2 rise due to a stretch (ii) a shear-mediated 
response to inhibit contractions via NO production. Specifically, this model predicts that 
NO is essential for the phasic contractions and without NO production phasic contractions 
are completely abolished; however, the modeling results have been questioned based on 
the ex-vivo studies of NO synthesis blockade showing spontaneous contractions develops 
and even improves in the absence of endothelial-derived NO [170,171]. The rat tail has 
previously been used to study the effect of dermal NO donor (GTNO) on the pumping 
function of the lymphatic vessels [172,173]. Using in-vivo experiments, it was shown that 
the pumping pressure, that is the maximum pressure that can be achieved along a lymphatic 
chain to maintain lymphatic flow, decreases with the administration of dermal NO [172]. 
Computational simulations and parametric studies based on the rat thoracic biomechanical 
properties suggested that the decrease in the amplitude of active contractions can explain 
the reduction in pumping pressure. In addition, we have recently used the rat tail to show 
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that the lymphatic vessels experience axial pre-stretch [168]. This study provides the ex-
vivo experimental data on the isolated lymphatic vessels and complements our previous 
knowledge regarding the effect of exogenous NO on lymphatic contractility. We showed 
that the administration of exogenous NO suppresses all aspects of lymphatic contractility 
in a dose-dependent way. Further, the constitutive framework and estimated parameter 
support the significance of the axial stretch in the lymphatic function. The constitutive 
framework and specific experimental data for the rat tail lymphatic vessel pave the way for 
the future experimental and computational studies both in the context of lymphatic 
physiology and pathophysiology. In particular, the recent results from rat tail lymphatics 
suggests that the rat tail is a promising option to develop animal models of lymphatic 
dysfunction. Specifically, the study of lymphatic remodeling due to the surgical 
interventions in the context of lymphatic pathologies such as lymphedema or other 
inflammatory scenarios remains an exciting area for future studies. The presented specific 




CHAPTER 4. THE RELATIONSHIP BETWEEN 
LYMPHANGION CHAIN LENGTH AND MAXIMUM PRESSURE 
GENERATION ESTABLISHED THROUGH IN VIVO IMAGING 
AND COMPUTATIONAL MODELING 
4.1 Aim 2: Milestones 3 
To establish a microstructurally motivated chemo-biomechanical framework 
based on the experimental observations in Aim1, to model passive and active responses of 
rat tail lymphatic vessels to mechanical/biochemical perturbation (axial stretch and 
nitric oxide). The third milestone is as follows:: 
Milestones 3: To study the response of a lymphangion chain to different loading conditions 
based on the constitutive modeling approach. 
Hypothesis III:  We test the hypothesis that the maximum pressure that can be achieved 
along a lymphangion chain correlates with lymphangion number and lymphatic muscle 
contractility in the chain. 
4.1.1 Introduction.  
Computational models have provided new insight into the mechanical, material, 
biological and geometric parameters that influence the effectiveness of the lymphatic pump 
under different physiologic scenarios [62,65,174–176]. Computational models are useful 
tools to help integrate observations made across different experimental platforms and can 
guide experimental design by identifying key parameters that are likely to have the most 
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profound effect on pumping for further validation. For example, computational studies 
have predicted that a longer chain of lymphangion can pump against higher opposing 
pressure gradients, a phenomenon that has also been reported in isolated vessel studies. 
However this relationship between chain length and pumping pressure has yet to be 
established in vivo. The major objective of this study was to determine if the relationship 
exists in vivo and to use a computational model to test the hypothesis that the increase in 
maximum pressure generation along a chain of lymphangions correlates with lymphangion 
number and active tension of lymphatic smooth muscle cells.  
To bridge the gap between the precise functional measurements that can be made 
in isolated vessels with the physiologic relevance of in vivo approaches, we have developed 
a computational model of lymphatic pumping populated with experimental data of 
lymphatic vessel biomechanics taken from isolated vessels. We then challenge this model 
in vivo using near infrared imaging of lymphatic pump function under normal conditions 
and with treatment by a dermally delivered nitric oxide donor. By combining both 
computational modeling and a new near-infrared imaging (NIR) imaging approach in 
which we measure lymphatic pumping pressure at multiple locations along a lymphangion 
chain, we establish an approach to approximate lymphatic muscle force generation in 
vivo.  We establish an approach to approximate lymphatic muscle force generation in vivo 
through non-invasive measurement of maximum pressure generation along a chain of 
lymphangion. 
4.1.2 Methods 
Pressure Measurement System 
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To evaluate the maximal pressure generation of lymphangion chains in-vivo, we 
utilized a previously described method to quantify lymphatic pumping pressure [177]. 
Briefly, these methodologies involve a closed-loop lymphatic pressure measurement 
system that was designed utilizing a commercially available pressure cuff (Kent Scientific, 
Torrington, CT). The pressure cuff was attached to a 5 mL BD luer-lock syringe via plastic 
tubing and to a pre-calibrated pressure transducer (Honeywell Sensing and Control, 
Morristown, NJ). The pressure transducer was connected to a data acquisition (DAQ) 
device (National Instruments (NI), Austin, TX) and pressure values were read into a 
LabView virtual instrument (VI) (NI, LabView 2014 32-bit). These real-time pressure 
readings were used to control the serial command output to the syringe pump (Harvard 
Apparatus PHD 2000 Infusion/Withdraw 70-2001). The difference between the desired 
pressure and the sampled pressure was used to control the flow rates on the syringe pump 
to subsequently inflate or deflate the pressure cuff.  
To determine the presence or absence of lymph flow at various occlusion pressures, 
the vessels were imaged with a lymphatic near-infrared (NIR) imaging system as described 
previously [177,178]. In brief, a diode driver and temperature control box powered a 1 W 
808 nm laser diode and a 20 beam diffuser (Thorlabs, Newton, NJ), which provided 
excitation light. This achieved a uniform excitation field of approximately 75 cm2 with less 
than 1.9 mW/cm2. An Infinity K2/SC video 2.15x magnification microscope lens (Edmund 
Optics, Barrington, NJ) and a bandpass filter (CW: 840 nm, FWHM: 15 nm, Omega 
Optical, Brattleboro, VT) were attached to a PIXIS 1024B back-illuminated CCD camera 
(Princeton Instruments, Trenton, NJ) to capture fluorescence emission centered at 840 nm. 
Experimental Protocol 
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All animal procedures were carried out at the Georgia Institute of Technology, 
Atlanta, Georgia and were reviewed and approved by the Georgia Institute of Technology 
Institutional Animal Care and Use Committee. A standardized procedure to quantify 
pumping pressure was carried out on nine week old male Sprague Dawley (Charles River, 
Wilmington, MA) rats. To minimize light scattering, a depilatory lotion was used to 
remove hair in the region of interest on the tail one day prior to experimentation. Rats were 
anesthetized with an intramuscular injection of diazepam (2.5 mg∕kg) followed by a 
cocktail of fentanyl (0.12 mg∕kg) and droperidol (6 mg∕kg). After waiting for approximately 
10 minutes for the anesthetics to take effect, the rat was positioned under the camera. 
Animals in the nitric oxide treatment group received a topical application of 500 mg 
glyceryl trinitrate ointment (GTNO, 0.2% wt∕wt, Rectogesic, Care Pharmaceuticals) 
applied to the entirety of the tail.  
The proximal edge of the pressure cuff was placed 4 cm, 8 cm, or 12 cm from the 
distal tip of the tail. The rat was positioned so that the field of view was immediately 
proximal to the cuff (Figure 4.1). A mixture of 30 µL of ICG/albumin solution (150 µg/mL 
ICG (Acros Organics, Geel, Belgium) and 60 g/mL bovine serum albumin (MP 
Biomedicals, Auckland, New Zealand) dissolved in deionized water was injected 
intradermally at the tip of the tail. 
Image acquisition began just prior to intradermal injection of the dye with a field 
of view that included the edge of the cuff and the proximal region (Fig. 4.1). Once steady-
state fluorescence was established, a predetermined sequence of pressure cuff applications 
was administered to the tail. Specifically, the pressure was increased to 80 mmHg for 10 
minutes to allow for the proximal vessel to completely empty its contents. After holding 
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for 10 minutes at 80 mmHg, the pressure was quickly decreased to 55 mmHg and then 
subsequently decreased in decrements of 2.5 mmHg, holding at each pressure step for 60 
seconds, until the pressure value reached zero. 
 Images of the tail were captured by the NIR imaging system throughout the 
experiment at a frame rate of 1 fps with a camera exposure time of 50 ms. After the first 
frame was captured, a region of interest (ROI) was selected that was positioned just 
proximal to the pressure cuff, over the fluorescent collecting vessel. The mean intensity 
within the ROI was recorded and used in conjunction with the pressure data to evaluate 
lymphatic pumping pressure. Effective pumping pressure was calculated using two points 
as described previously [177]: the minimum intensity value during occlusion at 80 mmHg 
and the maximum intensity value after flow was restored during deflation. The average of 
these two values was the intensity threshold for flow restoration. The pressure at the time 
where the intensity rose to equal this intensity threshold was the effective pumping pressure 
of the collecting lymphatic vessel. Animals were euthanized at the end of experiments 
using carbon dioxide (CO2). 
Statistical Analysis.  
Statistical significance between measurement taken at various locations was determined 
through a Kruskal-Wallis with a post-hoc Dunn’s test for multiple comparisons. The 
significant difference between the control and GTNO data sets was evaluated using the 
extra sum of squares F-test on the quadratic best-fit regressions of the data. For this test, 
the restricted model was a single quadratic regression for both data sets, corresponding to 
the null hypothesis that the control and GTNO sets can be sufficiently described by a single 
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quadratic regression. The full model was two quadratic equations for control and GTNO 
respectively, corresponding to the hypothesis that control and GTNO data sets were best 
described with two distinct quadratic regressions. The F-statistic was computed from the 
sequential sum of squares for the two models. To determine statistical significance, P-value 
was computed from the F-statistic with a P< 0.05 corresponding to a rejection of the null-
hypothesis. All statistical computations were performed in Prism software (GraphPad 
Software, La Jolla, CA). 
 
Figure 4. 1 Experimental set-up for measuring lymphatic pumping pressure. The pressure cuff is 
positioned at various locations measured from the tip of the tail. Flow restoration is imaged by 
capturing the return of fluorescence into the collecting vessel in a region proximal to cuff. The 
pressure at which flow restoration is observed is reported as the effective lymphatic pumping 
pressure and compared to Pb in the computational model. 
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Figure 4. 2 Geometric and micro-structural properties of rate tail lymphatics along various regions 
of the tail. A) – C) Cannulated lymphatic vessels isolated from regions 12 cm, 8 cm, and 4 cm from 
the tip of the tail respectively as shown in D). E) – G) Second harmonic generation images of 
collagen microstructure of vessels isolated from regions 12 cm, 8 cm, and 4 cm from the tip of the 
tail respectively. H) A chain of lymphangions showing typical valve spacing along the length of 
the chain. 
 Model Theoretical Framework. Our theoretical framework consists of a lump-parameter 
model for lymph transport, a 2D, non-linear, elastic, homogeneous, anisotropic model over 
finite deformation for the passive mechanics of the vessel wall, and a Rachev-Hayashi 
model for the active, contractile behavior of the vessel wall. 
Lymph Transport and Valve Function.  Lymph is transported through chains of 
lymphangions, separated by intraluminal one-way valves. Assuming fully-developed 
Newtonian flow, the Poiseuille law is used to calculate flow rate, which has been shown to 
be a good approximation in regions away from valves. The lymphatic valve imposes a 
variable resistance to flow during leaflet movements. This resistance becomes minimum 
during valve opening and maximum during the closure, while the opening/closure behavior 
is a function of trans-valvular pressure. The lumped model of valve resistance originally 
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proposed by Bertram et. al. is used to simulate the role of one-way valves. The valve 
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where RVn is the resistance of fully open valve, RVx is the resistance of fully closed valve, 
so is a parameter associated with the rate of opening and closure of valves, ∆pV is the 
pressure drop across the valve; ∆po is the pressure drop at which the valve opens or closes. 
 Passive contribution of extracellular matrix 
The passive circumferential and axial components of the 2-D Cauchy stress in the 
























𝑒  (9) 
where  𝐂e is the right Cauchy-Green strain tensor defined as 𝐂e = 𝑑𝑖𝑎𝑔{𝜆𝑟
2, 𝜆𝜃
2 , 𝜆𝑧
2},  where 
𝜆𝑟 = ℎ/𝐻, 𝜆𝜃 = 𝑑/𝐷, and 𝜆𝑧 = 𝑙/𝐿,  ℎ and 𝐻 are the loaded and unloaded thickness, 𝑑  
and 𝐷  are the loaded and unloaded diameter, and 𝑙 and 𝐿 are the loaded and unloaded 
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length of the lymphangion, respectively; 𝑊 is the strain energy density function which is 
adapted from the four-fiber family strain energy density function as: 
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𝑒  is the first invariant of 𝐂𝒆; 𝑏1
𝑘, and 𝑏2
𝑘 are material parameters associated with 
locally parallel collagenous fibers, (𝜆𝑘)2 = 𝐶𝜃𝜃
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 (11) 
where P and f are transmural pressure and axial force, respectively. 
Active contribution of smooth muscle cells 
 The lymphatic smooth muscle cells modulate contractile force generation in 
response to changes in transmural pressure of the vessels. A modified length-active tension 
relationship which was originally proposed for arteries by Rachev and Hayashi was 











where 𝑇𝑎𝑐𝑡(𝑡) is the activation parameter as a function of time that depends on the degree 
of muscle activation in response to variation in intensity of stimuli (e.g., intracellular 
calcium), which contributes to phasic contraction and tonic constriction, 𝜆𝜃 is elastic 
circumferential stretch, 𝜆𝑀 is the stretch at which force generation is maximum and 𝜆0 is 
the stretch at which force generation ceases. 
Assuming a cosine function for time-dependency of stimulation (e.g., intra-cellular 
calcium response) during phasic contraction and a constant parameter for contribution to 
tonic contractions, parameter 𝑇𝑎𝑐𝑡(𝑡) is written as: 
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where 𝑇𝑝ℎ𝑎𝑠𝑖𝑐 and 𝑇𝑡𝑜𝑛𝑖𝑐 regulate the magnitude of maximum phasic contractions and tonic 
constrictions, respectively; 𝑡 is time and 𝑡𝑐 is period of contraction. Additionally, a 
parameter 𝑡𝑟 is defined as the refractory period to separate consecutive contractions. 
Morphological and Biomechanical parameters 
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 Since circumferential stress depends on the unloaded configuration of 
lymphangion, the mean unloaded morphological parameters (diameter, thickness and 
length) in rat tail lymphatics were quantified from dissected collecting vessels (Figure 4.2, 
Table 4.1).  Male Sprague–Dawley rats weighing between 300 and 350 g were used for 
experiments, similar to those used for the in vivo measurement of effective pumping 
pressure. The rats were anaesthetized with a combination of a solution of fentanyl plus 
droperidol (0.3 mL kg−1 I.M.) and diazepam (2.5 mg kg−1 I.M.). To isolate lymphatic 
vessels from a tail region, an incision was made in the tail skin under the lateral caudal vein 
at the base of the tail to ligate lymphatic vessels to prevent them from leakage and keep 
them under pressure for easy identification. Tail skin with attached lateral caudal veins, 
arteries and lymphatics was removed from both sides of tail, the bone was discarded but 
tip of the tail was kept intact. Two stripes of skin with the vessel bundle were placed in a 
Petri dish (150x15mm) coated with Sylgard and filled with DPBS. The skin was pinned 
down to the bottom of the dish to expose vessels bundle on top. Lymphatic segments 
located at 4cm, 8cm, and 12cm from the tip of tail were identified usually lateral to the 
lateral caudal vein, as vessels were filled with near transparent fluid inside (lymph). Then 
they were carefully separated from blood vessels and nerves under a stereoscope using 
microsurgical forceps and scissors and cleaned (with caution not to grab or pinch vessels) 
from adipose and other connective tissue. The segment of tail lymphatic vessels without 
branches was cut and transferred to a vessel chamber, where it was cannulated and tied 
with 11 sizes of the surgical suture to ~200um glass cannulas and used for imaging. 
Collagen distribution was imaged with three-dimensional multiphoton imaging using 
second harmonic generation as described previously.  Given that the microstructure and  
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Table 4. 1 Parameters associated with biomechanical properties, geometry and valve models. The 
active parameters were taken from published values of thoracic duct in rats, valve parameters were 
taken from published measurements in rat mesenteric lymphatics, while geometric properties where 
measured directly in rat tail lymphatics. 
Biomechanical Parameter (Rat Thoracic Duct) Geometrical Parameters (Rat Tail) 
Passive  parameters Contractile  parameters Unloaded 
𝑏 (𝑃𝑎) 66.16 𝑇𝑎𝑐𝑡(𝑃𝑎) 10.9 Diameter(𝜇𝑚) 220 
𝑏1
1 (𝑃𝑎) 199.0 𝑇𝑝ℎ𝑎𝑠𝑖𝑐/𝑇𝑡𝑜𝑛𝑖𝑐 0.4 Thickness (𝜇𝑚) 7.85 
𝑏1
2 (𝑃𝑎) 0.14624 𝜆𝑚 1.4575 Length (𝑐𝑚) 0.33 
𝑏2




2 (𝑃𝑎) 0.48137   𝑅𝑣𝑛 (𝑃𝑎/𝑚𝑙) 60 
𝑏3
2 (𝑃𝑎) 189.9   𝑅𝑣𝑥 (𝑃𝑎/𝑚𝑙 ∗ 𝑐𝑚
2) 12e+10 
𝑏3
1 (𝑃𝑎) 0.46244   s𝑜 0.01 
𝛼1(𝑑𝑒𝑔𝑟𝑒𝑒) 90   Δ𝑝𝑜 0 
𝛼2(𝑑𝑒𝑔𝑟𝑒𝑒) 0   Flow  parameter  
𝛼3(𝑑𝑒𝑔𝑟𝑒𝑒)  27.7   Viscosity (cP) 0.01 
𝛼4(𝑑𝑒𝑔𝑟𝑒𝑒) -27.7      
𝜆𝑧 1.1     
 
Table 4. 2 Values of maximum active tension and associated geometrical properties of 
lymphangions for various organs in various species The active tension has been quantified using 
the wire myograph technique in which biaxial mechanical testing has been used. 






Human Thoracic Duct 2210 - 6.24±0.75 
Rat Thoracic Duct 404.5±10.1 10.8±0.9 0.59±0.03 
Rat Thoracic Duct 259.7±53.0 - 0.128±0.011 
Rat Thoracic Duct 480±21.8 32.2±1.6 0.52±0.14* 
Rat Cervical 236.0±19.5  8.10±0.6 0.37±0.03 
Rat Femoral 203.0±10.7 7.8±0.5 0.39±0.03 
Rat Mesentery 149.±14.1 6±0.7 0.34±0.02 
Rat Mesentery 105.9±0.00 - 0.380±0.02 
    
the geometry of lymphatic vessels were directly obtained from tail while the measurements 
for biomechanical properties of lymphatic vessel and lymphatic valves were obtained from 
thoracic duct and mesenteric lymphatic vessels, respectively (please see Table 4.1 and 4.2). 
Collagen distribution in rat tail lymphatics were qualitatively similar to that of the rat 
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thoracic duct, the active and passive parameters were obtained from previously 
experimentally quantified parameters. All those parameters are listed in Table 4.1. The 
model material properties that were used, specifically the passive parameters associated 
with collagen and elastin organization in lymph vessels and active parameters associated 
with the lymphatic smooth muscle cells, were selected within the range of what has been 
quantified previously through biaxial testing of rat thoracic duct and are summarized in 
Integrative Modeling 
 To obtain the flow rate generated by intrinsic contractions of lymphangions, an 
algorithm in Matlab 2010 was used to simultaneously solve constitutive equations of 
lymphangion’s wall mechanics, lymph flow as well as intraluminal valve models. This 
algorithm has been previously discussed in detail [71]. In brief, lymphangion constitutive 
equations of wall mechanics are composed of both passive model, which accounts for 
structure-function relationship of lymphatic vessel’s wall, and an active model, which 
constitute a framework to model active force generation of lymphatic smooth muscle cells 
that incorporates both tonic constrictions and phasic contractions. Both active and passive 
model parameters were informed by ex-vivo isolated lymphatic vessel experiments in rat 
thoracic duct (see Table 4.1). A parameter (Tact) that dictates the contraction and relaxation 
of lymphatic smooth muscle cells is prescribed to stimulate the phasic contractions and 
tonic contractility of smooth muscle cells. The contractile activity of a lymphangion is 
regulated by both mechanical stimuli (e.g. stretch response) and biochemical stimuli (e.g. 
calcium dose-response). The stretch-dependency of the lymphatic contraction model  
accounts for length-tension relationship of the muscle, while cyclic changes in amplitude 
of active tension (Tact) prescribes the time-dependent response. The parameter Tact can 
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oscillate between basal (diastolic) and maximum (systolic) values that ultimately determine 
systolic and diastolic diameters respectively. It should also be noted that the parameter Tact 
only determines the maximum amplitude of active-stress (regardless of stretch-response) 
at each time point of contraction.  When comparing the model to in vivo data, the parameter 
Tact was changed to find the best fit to experimental measurements. For the purposes of this 
study Tact was assumed to be constant along the length of the chain. In addition, parameters 
associated with the valve and flow models were adopted from previous studies (see Table 
4.1). The solving algorithm is based on an optimization routine to find diameter and 
pressure that satisfy mass conservation for each lymphangion (see Fig. 3.7.).  
Since the computational model was used to recapitulate the in-vivo lymphatic 
pressure-length relationship of a rat tail model, the geometrical parameters were measured 
from tail (see Table 4.1). To determine the number of lymphangions in the tail, the skin 
was removed from the tail region and upon application of trypan blue dye (0.4%) to identify 
lymphatic vessels, a long chain of lymphangions was observed.  Based on the measurement 
of the distance between two lymphatic valves under a streomicroscope (Zeiss SteREO 
Lumar.V12) using segments of a lymphangion chain at three different locations (4, 8, and 
12 cm from tip of tail), the average lymphangion number was approximated to be 3 
lymphangions/per centimeter in the rat tail. Since occlusion pressures were measured at 
three locations from the tip of tail (4 cm, 8 cm, and12 cm), three locations along the tail 
were modeled as chains with 12, 24, and 36 lymphangions based on the average number 
of lymphangions per centimeter of tail (3 lymphangion/per cm), respectively. The pressure 
at inlet of chain was set to 6mm Hg (an approximate pressure at the injection site near the 
tip of tail), which was based on an approximation of the y-intercept of a curve fitting the 
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experimental data where the number of lymphangions is mathematically zero. The outflow 
pressure was elevated until the flow rate dropped below 0.01 mL/min (equivalent to 
pressure applied through pressure cuff to occlude lymphatic flow).  
 
Figure 4. 3 The schematic of the solving routine for computational framework used to model a 
chain of lymphangions in a series arrangement.  
 
Figure 4. 4 The maximum outflow pressure at which flow can be achieved as a function of chain 
length using in vivo NIR measurements and computational modeling. The activation parameter 
(Tact) which is associated with the degree of smooth muscle cell activation is the sum of phasic 
and tonic activation parameters (see Eqs. (7)) and was iteratively solved for to provide the best fit 
for the experimental data.  SEM along with the mean at 4cm (n=3), 8cm(n=4), and 12 cm(n=5) 
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distance from the tip of tail were plotted. Statistical significance was determined through a Kruskal-
Wallis with a post-hoc Dunn’s test for multiple comparisons (p-value<0.05). 
4.1.3 Results 
Experimental and computational modeling results show that pumping pressure 
increases with chain length.  The effective pumping pressure in the rat tail 
progressively increases along the length of the tail as one moves from the tip of the tail 
towards the base (Figure 4.4). Specifically, the average pumping pressure for each group 
of rats was (15.2 +/-  5.17) mmHg (n=3), (21.3 +/-  5.06) mmHg (n=4), and (34.8 +/-  2.52) 
mmHg (n=5) and distances of 4 cm, 8 cm, and 12 cm from the tip of the tail respectively 
(p <0.05).  As the measurement site from the tip of tail increases the maximum occlusion 
pressure at which flow can be achieved increases. This phenomenon is also observed in the 
computational model where optimization of the activation parameter to provide the best fit 
to the data suggests a value of Tact=7.64 (kPa), which can be converted into a tension by 
multiplying by the vessel thickness to yield a value of 0.06 mN/mm. This is within the 
range but smaller than tension values reported in the literature for isolated rat lymphatics 
from other tissue beds (Table 4.1). The Pearson correlation coefficient between mean 
experimental data and computational data is r=0.914. 
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Figure 4. 5 Flow rate as a function of outflow pressure in the lymphangion chains: A) for different 
number of lymphangions in a chain with an activation parameter of Tact=10.9 (kPa) B) for different 
values of the activation parameter of smooth muscle cells in a chain with 36 lymphangions.  
Parametric studies: Contractility strength and number of lymphangions modulate 
pumping pressure and flow rate.   To explore further how the number of lymphangion 
in a chain and the stimulation of smooth muscle cells might influence this observed 
pressure-length relationship, we utilized the computational model to plot the relationship 
between flow rate and outflow pressure for a lymphangion chain with different numbers of 
lymphangions and varying activation parameters (Figure 4.5). As the number of working 
lymphangions within a chain increases (while holding Tact=10.9 kPa) a non-zero flow rate 
can be achieved at higher opposing pressure gradients (Fig. 4.5A). Additionally, an 
increase in contractile strength via a larger activation parameter in a chain with 36 
lymphangions results in sustaining flow at a higher confronting pressure gradient (Fig. 
4.5B). Ultimately when there are many lymphangions in series there appears to be a 
nonlinear relationship between occlusion pressure and the number of lymphangions in a 
chain (e.g., for a chain with 36 lymphangions and Tact=8.7 kPa, the empirical fit of 
occlusion pressure = -0.0089n2 + 1.0431n provides a better fit than a linear one (R² = 
0.9986)). At a lower lymphangion number the relationship appears to be reasonably 
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approximated by a linear fit (e.g., for a chain with 6 lymphangions and Tact=8.7 kPa, R² = 
0.9609) that is dependent upon the contractility of the smooth muscle cells (Figure 4.4). 
This implies that the lymphangion chain with higher degree of smooth muscle cell 
activation is more capable to overcome higher pressure along the chain and that each 
lymphangion contributes to build up a pressure gradient to propel flow against an adverse 
pressure gradient.   
 The theoretical maximum flow that can be achieved under the pressure scenarios 
modeled here occurs when no adverse pressure gradient is present (i.e. the outlet pressure 
of the chain equals the inlet pressure). While increased smooth muscle cell activity 
increases the maximum flow rate that can be achieved through the network, the total 
number of lymphangions within the chain has very little effect on maximizing flow in the 
absence of an adverse pressure gradient (Figure 4.6). Stated another way, increasing the 
number of lymphangions within a given length of vessel would enhance that vessels ability 
to overcome adverse pressure gradients, but would not have a substantial benefit for 
enhancing lymphatic flow.  
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Figure 4. 6 Muscle activation (Tact) and the number of lymphangions in a chain, both serve to 
increase the maximum pressure generation capacity of a lymphatic chain. Tact and lymphangion 
number are both varied over ranges that have been measured in vivo. Tact=10.9 kPa ( y =1.3733x 
; R² = 0.947); Tact=8.7 kPa ( y = 1.0526x;R² = 0.9609); Tact=6.6 kPa (y = 0.7026x; R² = 0.9517) 
; Tact=4.4 kPa ( y = 0.3619x; R² = 0.908), where x and y denotes outflow pressure – inflow pressure 
and lymphangion number respectively. 
Parametric studies: Contractile frequency has little effect on maximum pumping 
pressure.  Many in vivo studies that utilize NIR imaging rely primarily on lymphatic 
contractile frequency as a measure of lymphatic function, yet it is unclear how exactly 
contractile frequency changes lymph flow in different physiologic scenarios. To 
investigate the effect of lymphatic contractile frequency on both flow rate and maximal 
pumping pressure, the computational model was used to vary the refractory period between 
contractions (Figure 4.8). A contraction cycle is composed of a contraction time (rhythmic 
contraction) as well as a refractory time (time at which the diastolic diameter is held 
constant). Thus, the frequency of contraction is the reciprocal of the sum of these two 
contraction times. Under a minimal adverse pressure gradient, increased contraction 
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frequency (i.e. decreased refractory time) enhances lymphatic flow, unless there is an 
adverse pressure gradient. However, in the presence of an adverse pressure gradient, the 
benefit of increased pumping frequency is diminished. Increased contraction frequency 
increases lymphatic pumping pressure for frequency ranges less than 10 cpm, however, the 
benefit of contraction frequency to pumping pressure is diminished at values larger than 
this (Fig. 4.9). Interestingly, when compared to in vivo data there is no correlation between 
the contraction frequency of a lymphatic pre-occlusion and the resulting pumping pressure. 
However, it should be noted that the current experimental set-up does not allow one to 
track packet frequency distal to the occlusion while pumping pressure measurements are 
Figure 4. 7 Maximum flow rate that can be achieved, when there is no adverse pressure gradient 
present, due to the intrinsic contraction of lymphangions with a different number of lymphangions in 
the chain as a function of lymphatic smooth muscle activation (Tact). 
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being made, making it unclear whether this frequency - pressure generation relationship 
occurs in vivo. 
 
Figure 4. 8 The effect of refractory time on A) flow rate and maximum pressure in a chain of 8 
lymphangions, B) flow rate generated by intrinsic contraction of lymphangions for chains exposed 
to different opposing outflow pressures. 
 
Figure 4. 9 The effect of frequency on maximum pressure that can be overcome by a lymphangion 
chain to maintain flow rate. A) computational results for a chain of 8 lymphangions, Tact=10.9 
(kPa). B) experimental results from the rat tail model demonstrate that there is no correlation 




 Experimental and computational modeling results concur that dermal nitric oxide 
donor diminishes maximum pumping pressure.  Given the model’s prediction that the 
maximum outflow pressure is highly dependent on lymphatic muscle activity, we sought a 
method to experimentally alter 𝑇𝑎𝑐𝑡 in vivo by treating the tails of rats with a dermal cream 
(GTNO) containing a nitric oxide donor.  
The average pumping pressure for each group of rats was found to be (10.3+/-4.02) mmHg 
(n=4), (12.43+/- 5.80) mmHg (n=3), (18.54+/-3.4) mmHg (n=12), and distances of 4cm, 
8cm, and 12 cm from the tip of the tail, respectively. Comparing to control and GTNO data 
sets using the extra sum of squares F-test on the quadratic best-fit regressions of the data 
revealed that the two groups are statistically different. This relies on the fact that 
Figure 4. 10 The effect of dermal nitric oxide delivery on the relationship between maximum outflow 
pressure and length from the tip tail using in vivo NIR pumping pressure measurements and the 
computational model. The activation parameter which is associated with the degree of smooth muscle 
cell activation that best fits the in vivo NO experiments was found to be Tact=4.4 (kPa). SEM along 
with the mean at 4cm (n=4), 8cm(n=3), and 12 cm(n=12) distance from the tip of tail were plotted. 
Significant difference between the control and GTNO data sets was determined using the extra sum 
of squares F-test on the quadratic best-fit regressions of the data (p-value<0.05). 
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application of NO resulted in the attenuation of the pumping pressure that was more 
pronounced as one increases the number of lymphangions in the chain. Thus, treatment of 
the lymphatic chain with dermal NO compromises its capability to maintain flow rate in 
the presence of a confronting pressure. Using the computational framework, decreasing 
contractile strength via a reduction of the activation parameter by approximately 40% 
(from 76.4 to 43.7) can capture these experimental observations (Fig. 4.10). 
4.1.4 Discussion  
While significant advances have been made towards understanding the molecular 
regulation of lymphatic contractility both in isolated vessels and in small animal models, 
there remains a significant gap in our understanding of how networks of lymphangions 
work across long distances to move fluid against the unfavorable pressure gradient that 
exists in vivo. Recent advances by several groups have demonstrated the ability to measure 
lymphatic pumping pressure in both clinical and animal research settings. Similar to blood 
pressure, which provides a measurement of cardiac pump function, the technique has been 
suggested to be indicative of the combined capacity of the intrinsic and extrinsic lymphatic 
pumps. However, unlike the cardiovascular system, in the lymphatic system the vessels 
themselves are the primary source of pressure generation and vascular resistance. This 
would suggest that any measurement of lymphatic pumping pressure will be highly 
sensitive to the number of lymphangions that are contributing to pressure generation and 
thus the location on the appendage that the measurement is made. By combining 
computational modeling built on experimental measurements of lymphatic vessel 
mechanical properties, with in vivo measurements of lymphatic pumping pressure along 
various locations in the rat tail, we show that pumping pressure changes over the length of 
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the vessel and that this change in pumping pressure depends on both the number of 
lymphangions engaged in pumping and the contractile force of the muscle generating the 
contractions. In the rat tail model, this allows one to record a direct measurement of the 
intrinsic pump, although it remains to be seen if the intrinsic pumping capacity can be 
decoupled from the extrinsic pump (e.g. skeletal muscle contraction in a human arm) where 
extrinsic contractility is thought to significantly contribute to the transport capacity. 
 In addition to enabling the in vivo measurements of lymphatic muscle contractility, 
the computational model also allows for the investigation of how various parameters affect 
the maximum outflow pressure that can be achieved for a given lymphangion chain. This 
is important since the lymphatic system is typically exposed to hydrostatic pressure 
gradients that oppose flow from the interstitial space to the venous system, and thus 
lymphatic smooth muscle cells must impart energy to propel flow through the network. 
Although intrinsic pump activity enables lymphatic vessels to pump over a larger range of 
transmural or outflow pressures, the further elevation of outlet pressure outside of this 
range induces pump incompetency. The simulations show that flow rate declines with an 
increase in maximal outflow pressure as exposing a lymphangion chain to higher outflow 
pressure results in the progressive inability of lymphangions to empty, an observation that 
is consistent with isolated vessel experiments is also in agreement with other computational 
models of lymphangion chains. The simulation results suggest that both the degree of 
smooth muscle cell activation and the number of working lymphangions directly influence 
this relationship between flow and outflow pressure. In the context of lymphedema, it has 
been suggested that patients with a higher lymph load are predisposed to disease, 
motivating the need for further studies that explore how prolonged elevated demand on the 
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intrinsic lymphatic pump might drive fatigue of lymphatic muscle force generation and 
thus lymphedema. While, smooth muscle force generation of lymphatics likely exhibit 
regional and species variations, the values for the model that best fit the in vivo data are 
within the range of those measured experimentally from other tissues tested ex vivo (Table 
3.3).    
  Frequency of lymphatic pumping has become a very common measurement that is 
suggested to be indicative of lymphatic function. However, if the ultimate function of 
lymphatics is to generate flow, contraction frequency by itself may not always accurately 
reflect function. This has been suggested by both in vivo experiments, where flow can be 
observed in certain situations even when the vessel is not contracting and in isolated vessel 
experiments in which imposed flow actually serves to inhibit lymphatic contraction and 
conserve energy [179]. This is also evident through the in vivo experiments reported here, 
where the baseline contraction frequency of an animal does not necessarily reflect the 
maximum pressure generation capacity of the lymphangion chain (Fig. 11). The 
computational model suggests that the benefit of contraction frequency to pressure 
generation by a lymphangion chain plateaus at values above 10 cpm. These results raise 
doubt as to whether focusing on contractile frequency as the primary metric of lymphatic 
dysfunction is a clinically relevant endeavor for explaining lymphatic failure in 
lymphedema. 
 It is important to note that isolated vessel studies have demonstrated that 
contraction frequency increases under an elevated outflow pressure [121]. This pressure 
dependence on the contractile frequency is not incorporated into the current model and 
would be a valuable feature to include in future iterations. However the model and the in 
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vivo data still support the idea that the generated pressure gradient along a chain confronted 
with a high adverse pressure is mainly due to the contractile strength of lymphatic smooth 
muscle cells and the number of lymphangions present. While Tact contains both the effects 
of tonic constriction and phasic contractions, the current study assumes that the ratio 
between these two is constant and thus cannot decouple the independent effects of the two. 
Although we include intraluminal valve function through modeling variable resistance to 
lymph flow from opening to closure as a function of transaxial pressure gradient along the 
valve, there is a known dependency of the valve resistance behavior on the transmural 
pressure (or circumferential stretch ) [118], which is neglected in this model. Including this 
feature in future iterations of the model would likely further enhance the benefit of Tact on 
enhancing the effective pumping pressure, as the elevated myogenic constriction under a 
large transmural pressure would improve valve function.  
 This study has several limitations that should be noted. First, although the 
microstructure-based model captures many of the salient features of pumping function in 
a lymphangion chain, the comprehensive experimental quantification and validation of 
model parameters in the specific anatomical region of interest are still needed.   There is 
experimental evidence that lymphatic vessels from different regions have adapted their 
contractile force in line with the particular in vivo pressure experienced by the lymphatic 
vessel [122,180].  An example in rat is the femoral lymphatic vessel which shows the 
highest capability to adapt its contractile force to withstand high pressure, while thoracic 
duct exhibits the lowest capacity to overcome elevated pressure [122]. In contrast, the 
thoracic duct is known to be very sensitive to wall shear stress and thereby is able to switch 
between pump and conduit modes. The ideal computational approach requires 
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experimental measurements of valve resistance and biomechanical material properties 
across a chain of vessels within the tail, as it is unknown how these parameters vary along 
the length of a chain of lymphangions. Additionally, the extent that the surrounding matrix 
provides structural support and the mechanical properties of said matrix vary from one 
tissue bed to another, could be salient features to include in the model. This is particularly 
important in the context of lymphedema where fibrosis of the interstitium is known to alter 
the surrounding matrix. In the absence of such information, we have invoked 
experimentally derived parameters form other lymphatic tissue beds including a valve-
model which has been validated previously in rat mesenteric lymphatic vessels and passive 
biomechanical properties quantified in rat thoracic duct. In addition, the heterogeneity of 
biomechanical properties, as well as the complex topology of the lymphatic network (e.g., 
branches in region near tip of tail), are neglected in this study. Thus, the direct measurement 
of model properties along with a better understanding of network properties in the 
lymphatic vasculature to validate intraspecific (e.g, tail, mesentery, thoracic duct, limb and 
popliteal vessels) and interspecific (e.g, rat, sheep and human) pressure-length 
relationships remains an area for future studies.  
 Lastly, it is difficult to narrow down the specific mechanism by which NO is 
decreasing lymphatic pumping pressure. Previous studies in isolated vessels have shown 
that excess nitric oxide lowers both the frequency of contraction, vessel tone, and 
contraction amplitude [121,181]. In vivo studies involving fluorescent tracers have shown 
that NO decreases frequency of contractile events and/or tracer clearance rate [173,182–
184]. However, NO is also known to alter microvascular permeability [185], and thus it is 
difficult with in-vivo experiments to pin down the exact mechanism by which NO is 
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altering function. Our computational model and experimental results show that the 
reduction in effective pumping pressure is likely not primarily due to its effects on 
contraction frequency or interstitial fluid pressure, but rather be captured by its influence 
on Tact. However, since Tact includes both the combined effects of tonic constrictions and 
phasic contractions, it is not clear in this study whether NO effects on tone (and indirectly 
valve function) or contraction amplitude are primarily responsible. 
In summary, through computational modeling and a novel implementation of lymphatic 
pumping pressure measurements using NIR imaging, we show that the maximum outflow 
pressure that a lymphangion chain can overcome is a function of the number of 
lymphangions in the chain and the active tension generation by the lymphatic muscle cells. 
By fitting our computational model to experimental measurements of the pumping pressure 
at multiple locations along the tail, we can estimate the average force generation for the 
chain of lymphatics, decoupling the intrinsic function of that vessel from other extrinsic 
factors such as interstitial fluid pressure at the injection site. Although measurement of the 
maximum pumping pressure is known to have the potential as a clinical diagnostic 
approach for lymphedema [186,187], this study suggests that any measurement of the 
maximum pumping pressure should be interpreted in the context of chain length; and 
hence, measurements should be performed at multiple locations to provide sufficient 
information on lymphatic muscle activity in the limb of interest. Since this approach is 
non-invasive, the potential as a clinical diagnostic in lymphatic health is promising and 
future trials in humans are warranted to establish feasibility. The ability to obtain a direct 
measurement of lymphatic muscle health in a clinically relevant scenario remains lacking, 
and would be a substantial benefit to future diagnostic capabilities.   
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CHAPTER 5. LYMPHATIC REMODELING IN RESPONSE TO 
INJURY 
5.1 Aim 3: 
In this chapter, I test and show the feasibility of developing a microsurgical ligation 
model in the rat tail to study the prolonged adaptations of collecting lymphatic vessels to 
mechanical overloads. There is one milestone for Aim 3 as follows: 
Milestone: Developing a novel lymphatic injury model in the rat tail and testing the 
feasibility of using this animal model to study load-induced remodeling in collecting 
lymphatic vessels via in-vivo imaging and ex-vivo experiments on the isolated vessels. 
Hypothesis I: I test whether the surgical removal of relatively large segments of lymphatic 
vessels from one side of the tail triggers a remodeling response resulting in a progressive 
decline in lymphatic function. 
5.2 Introduction  
The lymphatic system is found in almost all soft tissues and plays a fundamental role in 
maintaining tissue’s fluid balance, immune function and absorption and transport of lipids 
[1]. The lymphatic system has a hierarchical architecture that enables lymph transport from 
the interstitial space through specialized lymphatic capillaries and ultimately larger 
collecting ducts that returns lymph back to the great veins [2]. Contractile units of the 
lymphatic system called lymphangions have been equipped with specialized muscle cells 
that enable the vessels to spontaneously contract to propel lymph against the gravity and 
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an adverse pressure gradient from the interstitial space to the venous system. Since the long 
chain of contracting lymphangions need to be orchestrated to efficiently transport lymph, 
lymphatic vessels are tightly regulated by biochemical (e.g., vasoactive agents such as NO, 
histamine, etc), mechanical (e.g., stretch due to pressure) [3–6,10,15–17].  
Not surprisingly, impaired lymphatic pumping has been implicated in debilitating diseases 
such as lymphedema where the stagnation of lymph drives tissue swelling, chronic 
inflammation, fibrosis, and infections. It has been suggested the damage to the lymphatic 
system during modalities of cancer treatments induce microstructural remodeling in 
collecting lymphatic vessels [188]. In particular, morphological changes in different stages 
of lymphedema development suggest that the lymphatic dysfunction may be a result of a 
gradual remodeling that might occurs months to years prior to the onset and progression of 
lymphedema [189]. This idea is support by the incident rate of lymphedema and variability 
in the disease onset. Typically, the incidence of lymphedema increases with time and most 
patients develop lymphedema months to years post lymph-node dissection.  Although 
minor swelling after the initial surgery resolves spontaneously, the persistent swelling 
recurs in lymphedema patients 8-24 post-surgery [190]. Generally, it is hypothesized a 
gradual remodeling response in the lymphatic system and abnormal development of 
lymphatic contralateral lymphatic are the major drivers of lymphedema progression [191].  
Mouse models of lymphedema have provided valuable information regarding lymphatic 
growth and remodeling (G&R)  post-lymphatic injuries [54,177]. In the typical mouse tail 
lymphedema model, all initial and collecting lymphatic vessels are cauterized around the 
tail circumference to occlude pathways of lymph transport [192].  
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Currently, there is the scarcity of small animal models available to mimic human lymphatic 
dissection where relatively large segments of lymphatic vessels are removed while most 
initial lymphatics remain functional except at the incision site.  There are both single and 
double ligation models to induce lymphedema via the surgical model of lymphatic injury 
[54,193].  One challenge with the mouse model is the small size of mouse tail lymphatic 
vessels, which makes the isolation of these vessels difficult. To tackle this challenge, we 
develop a novel rat tail model of lymphatic injury where relatively large segments of 
collecting lymphatic vessels are ligated via a small incision to the skin and microsurgical 
ligation of collecting vessels while contralateral in the opposite side of the tail is being kept 
intact. The size of the rat tail is an advantage that makes it possible to study morphology 
and material properties of isolated vessels post-surgery. The collecting lymphatic vessels 
exposed to prolonged pressure/flow overloads respond to negative feedback of the 
lymphatic muscle cell’s (MCs) hypertrophy/hyperplasia, ECM remodeling, and altered 
contractility that ultimately leads to the gradual attenuation of lymphatic pumping.  
5.3 Methods 
Animal model and surgical procedure. Sprague Dawley (SD) male rats (Charles River, 
Wilmington, MA, 280-350 gr) were used in this study. Rats were anesthetized using 
ketamine (40mg/kg), DEXDOMITOR® (dexmedetomidine hydrochloride)  (0.13.mg/kg).  
Once the animal reached a surgical plane of anesthesia, an incision (~1 cm) was made in 
one side (left side) near the base of tail to gain access to the lateral tail vein. Trypan Blue 
Solution 0.4% dye was injected downstream of the incision site to enhance the visibility of 
lymphatic vessels. Upon identifying two chains of the rat tail lymphatic vessel (size~ 
250µm-350µm) under a dissecting microscope, two large segments of the collecting 
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lymphatic vessels (~1-2 cm) were surgically ligated using the microsurgical scissors (Fine 
Science Tools, Inc). The incision site was sutured using Suture 4-0 Silk Black (ETHICON 
SUTURE, Inc). Once the procedure is completed, ANTISEDAN (1.3 mg/kg) was injected 
for the reversal of the sedative and analgesic effects of DEXDOMITOR®. To perform the 
isolated vessel experiments post-surgery, we use a similar approach where the dissected 
vessels were placed in Dulbecco’s Phosphate Buffered Saline (DPBS, Corning). Once the 
surrounding fat and connective tissues were removed, the lymphatic vessels (containing 
approximately ~2-3 cm and containing 1-2 valves) were mounted on opposing cannula in 
a custom-made vessel chamber [75]. All the protocols were approved by Georgia Tech's 
Institutional Animal Care and Use Committee (IACUC). 
Near-infrared imaging and metrics. We utilized a previously developed lymphatic near-
infrared (NIR) imaging system to quantify functional lymphatic transport in-vivo. This 
system uses a shutter Instruments Lambda LS Xenon arc lamp, an Olympus MVX-ZB10 
microscope, a 769 nm bandpass excitation filter (49 nm full-width half maximum, 
FWHM), an 832 nm bandpass emission filter (45 nm FWHM), and an 801.5 nm longpass 
dichroic mirror [54]. A volume of 20 μL of a NIR fluorophore 475 IRDye 800 CW NHS 
Ester (929-70020, LI-COR Biotechnology, Lincoln, NE) bound to 40kDa 476 
methoxypolyethylene glycol (mPEG) (JenKem Technology USA, Plano, TX) was injected 
into the tip of rat tail. This volume was chosen based on the previous experiments and tail 
experiments to provide sufficient dye volume to image the collecting lymphatic vessels 
in the rat tail. A Photometrics Evolve Delta 512 EM-CCD camera was used to acquire 
images at a frame rate of 10 fps with a camera exposure time of 100 ms throughout 
experiments. 
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To analyze functional NIR metrics, we used previously reported metrics including 
packet frequency, packet amplitude, and packet transport as follows [54]: 
Packet frequency: the number of peaks in the fluorescence signal per minute in vivo 
Packet amplitude: the amplitude of NIR signal packet 
Normalized packet amplitude: the normalized amplitude of NIR signal packet 
Filling time: the time needed the dye fills vessels from baseline value to the maximum 
value prior to the contraction 
Light Sheet Microscopy. To perform light sheet microscopy images were acquired using 
a Zeiss Lightsheet Z.1 microscope equipped with dual PCO.Edge sCMOS cameras and 
dual side illumination with pivot for multiview acquisition that allows high-resolution 
imaging of samples with minimal photobleaching. Two laser line of 488nm (50mW) and 
638nm (75mW) were used for acquisition in the combination of 5X/ 0.16 N. A. with 5X 
0.1 N.A. illumination objectives. Vessels were filled with 1% Agarose, low gelling 
temperature, Type VII-A, (Sigma-Aldrich #A0701) in temperature of 38 0C prior to 
imaging. After agarose has polymerized in room temperature, vessel was with 1% agarose 
and mounted on the glass capillaries (BRAND 701904 volume 20 μL) using the plunger 
(Brand #701932) for suction. Capillary was mounted in microscope holder and specimen 
chamber filled with diH2O. After the gel has polymerized the plunger was used to push 
out the specimen. 
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Thickness Measurement. Light sheet images were analyzed using Image J software to 
calculate average thickness based on the thickness at different sections along the vessel 
length (6 sections).  
Immunostaining. The protocols are the same as the previous protocols presented in 
Chapter 2 (section 2.1.2.7). 
Biaxial testing system. We used our previously developed and improved biaxial testing 
device customized to study the biomechanics of lymphatic vessels [81]. A custom-written 
program in LabVIEW was used to control transmural pressure via a syringe pump 
movement (Harvard) and the precise pressure sensors (1psi SSC series, Honeywell). Linear 
actuators and XYZ stages (Newport Precision, LTA series and M-461 series) were used to 
control the axial stretch. Axial forces were measured using a 50mN force transducer 
(Aurora Scientific, Model 400A). Using an inverted microscope and a custom-made 
chamber. Using the LabVIEW program, the diameter of the vessel, obtained from an 
inverted microscope (2.5x magnification) and digital camera (Allied Vision Technologies, 
Marlin F-033B) capturing at 18 fps tracing, was recorded in real-time and saved to the hard 
drive for further analysis. For the passive biaxial testing, Ca2+-free PBS solution (Corning® 
Phosphate-Buffered Saline, 1X without calcium and magnesium, PH 7.4 ± 0.1) containing 
3mM EDTA [70,159] was used to inhibit vessel contractility. All vessels were 
preconditioned by ramping the transmural pressure from 0 to 10 mmHg while at three 
stretch steps of 10%, 20%, and 30%. Those values were chosen based on our previous 
study to quantify the biaxial properties of rat tail lymphatics. 
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Statistics. To determine the statistical significance between injured and contralateral and 
sham groups, a one-way ANOVA in conjunction with Dunnett’s post hoc test was used to 
make multiple comparisons. The statistical analyses were performed using Prism 5 
(GraphPad Software) with significance set at p < 0.05. All results were reported as means 
(±SEM).  
5.4 Results 
Surgical ligation of lymphatic vessels in the rat tail mimics lymphatic injury in clinical 
settings. Most surgical interventions that result in lymphatic dysfunction such as lymph 
node dissection involve lymphatic injury. To investigate how collecting lymphatic vessels 
respond to surgical injury, large segments of lymphatic vessels from one side of the tail 
were ablated to disrupt transport while contralateral vessels on the opposite side of the tail 
were kept intact. All animals were monitored to have properly ablated lymphatic vessels 
and the incision site was sutured at the end of the procedure. Since the surgical procedure 
was minor, the animals undergoing the procedure shows a very high survival rate (99%>) 
with minimum symptoms post-surgery. It remains possible that in some cases the ligation 
procedures cause acute inflammation rendering vessel harvesting challenging. To address 
this concern, the procedure was only limited to animals with properly ligated lymphatic 
vessels and excluded animals in which blood vessels were accidentally ligated (Fig. 5.1). 
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Figure 5.1 A representation of surgical procedure. (A) Lymphatic vessels were visualized via 
injection of Trypan blue dye (B) Large segments of lymphatic vessels were removed (C) The skin 
was sutured at the end of the procedure.   
A remodeling/lymphangiogenic response reroutes ligated collecting vessels to dermal 
initial lymphatics following lymphatic injury. Near-infrared (NIR) imaging allows the 
assessment of lymphatic function and regeneration in-vivo. Our imaging data demonstrate 
a remodeling response as early as two weeks post-surgery showing the generation of 
dermal lymphatics to bypass the injured vessel. Interestingly, NIR data suggest this 
remodeling response connects the injured vessels to intact contralateral vessels on the 
opposite side via the network of dermal lymphatics. Further, functional imaging suggests 
that contraction frequency of the vessel distal to injury site increases but returns to the 
baseline value four week post-surgery (Fig. 5. 3 A).  Average packet amplitude of injured 
vessels decreased postsurgery, however, the baseline value of injured vessels is larger 
(Figs. 5. 3 B and D). 
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Figure 5. 1 Longitudinal NIR imaging for both injured and intact contralateral lymphatic vessels. 




Figure 5. 2 Longitudinal functional NIR imaging for both injured and intact contralateral lymphatic 
vessels. A) Frequency of contractions B) Average amplitude of packets. * Indicates significance 




Figure 5. 3 Immunostaining of an injured and the intact contralateral lymphatic vessel from the rat 
tail. Vessels were stained for lymphatic smooth muscle cell and collagen and images were obtained 
using confocal microscopy. 
 
Figure 5. 4 Light-sheet microscopy of lymphatic vessels for injured and intact vessels. Vessels were 
stained using Alexa Fluor™ 633 Hydrazide to stain elastin and collagen. The average thickness of 
the injured vessel is thicker compared to the intact vessel. The thickness was obtained based on the 
average thickness along the length of the vessel. This measurements were performed on a  single 
pair of lymphatic vessels from a single animal. Statistical significance was assessed using a non-
parametric t-test and ** indicates p<0.005. 
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Histological assessments reveal altered lymphatic function in both ligated and intact 
vessels following lymphatic injury.  Immunostaining for two vessels from the injured site 
and intact site suggests that the structure of contralateral and injured vessels are different. 
Staining for lymphatic muscle cells (a-SMA) suggests that the injured vessel has irregular 
and thicker muscle bundles compared to the intact vessel (Fig. 5.4). The experiments were 
performed on a single pair of lymphatic vessels from a single animal. Further, based on the 
light sheet microscopy for whole immunostaining of the same vessels with Alexa Fluor™ 
633 Hydrazide, ligated vessel looks to be fibrotic and thicker compared to the intact vessel 
(Fig. 5.6). Collagen deposition is observed in the valvular region in the injured vessel while 
in the intact vessel less collagen is observed. 
 
Figure 5. 5 A representation of pressure-diameter biaxial testing from injured and contralateral 
vessels from the rat tail. 
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Figure 5. 6 Biomechanical properties of rat tail lymphatic vessels from injured and intact 
contralateral vessels using a three-fiber family model (injured n=3; intact n=3, control n=5). No 
statistical significance was observed between different groups. 
Ex-vivo multi-axial testing reveals structural and material remodeling following 
lymphatic injury. To investigate the effect of overloads on the biomechanical properties 
of lymphatic vessels post-lymphatic injuries, biaxial testing was performed on the isolated 
vessels from both injured and intact contralateral vessels. The results suggest that the 
biomechanical properties of injured vessels are different from the intact contralateral 
vessels (n=6 vessels). As shown in Fig. 5.6 and 5.7, vessels distal to the injured site seems 
to be stiffer compared to the contralateral vessel on the opposite side. Fitting biomechanical 
properties using a three-fiber family model (Eq. (12); chapter 3) suggests that material 
properties of a ligated vessel and intact contralateral are different.  
5.5 Discussion  
Post-surgical lymphedema is a challenging disease associated with dysfunctional 
lymphatics and clinically manifested by tissue swelling and fibrosis in patients who have 
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undergone cancer therapies and surgeries [194–196]. Although our understanding of the 
lymphatic system has been significantly improved over the past decade, the disease 
etiology still remains unknown [197]. Since the clinical manifestation of the disease can 
be delayed months to years after the surgery, the general notion is that lymphatic 
remodeling might occur months to years before the disease onset [40]. Despite efforts to 
study lymphedema onset and progression, much remains unknown. Particularly, the 
mechanics of lymphatic vessels in disease is an area that remains to be investigated, despite 
its importance in lymphatic remodeling. One challenge is the scarcity of successful animal 
models of lymphedema. For example, mouse models of lymphatic injuries from the tail 
have been a successful model helping us grow our knowledge of postsurgical lymphedema 
[50–52], however, the diminutive size of vessels compared to other species has been an 
obstacle to study mechanics. Here, we introduced a novel rat tail model representing a long 
chain of lymphatic vessels with a larger size. In addition, since the human lymphatic 
network is composed of coordinated chains of vessels to efficiently pump lymph, the study 
of lymphatic function or dysfunction in the context of a lymphatic chain provides more 
insight into the function or dysfunction of the lymphatic system [74,174]. The rat tail model 
provides a unique anatomy due to the close arrangement of parallel collectors compared to 
other tissue beds.  That could be an advantage to study lymphatic vessel remodeling 
compared to vessels from beds where greater distances between collectors are present. 
Overall, the size and accessibility of lymphatic vessels from rat tails make it suitable to 
bridge the gap in our knowledge of lymphatic biomechanics in health and disease, while 
still taking advantage of a small animal model.  
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Recent histological assessments in a novel mouse model of lymphatic injury have shown 
that lymphatic vessels exhibit abnormal structure following lymphatic ligation [54]. The 
vessel located at the distal side of the wound showed dilated lumen and abnormal valve 
morphology associated with permanent decline in lymphatic pumping generation.  Using 
our novel animal model we tested and showed the feasibility of surgical lymphatic ligation 
in the rat tail as a novel system model to study the remodeling of collecting lymphatic 
vessels following lymphatic injury. Our animal model was aimed to provide a novel 
microsurgical animal model to study structural and material remodeling of collecting 
lymphatic vessels. Our in-vivo imaging and histological analysis suggest that vessels distal 
to the ligation site undergo structural and functional remodeling. This observation supports 
the previous clinical observations of lymphatic remodeling following lymphatic injury. For 
example, a biopsy study of lymphedema patients has suggested lymphatic vessels the 
collecting vessels undergo sclerosis and muscle proliferation especially in the later stages 
of lymphedema. 
Our in-vivo imaging demonstrates a remodeling/lymphangiogenic response reroutes 
injured vessels to dermal initial lymphatic to either bypass the injured site or connect an 
injured vessel to intact contralateral. This has significant clinical implications as it suggests 
that vessels that show a higher density of the collateral formation exhibit a more noticeable 
loss of lymphatic function. Historically, it is believed that an impaired regeneration process 
after surgical insult, in particular, an impaired collateral formation of lymphatic vessels, 
drives the lymphedema onset and progression [189]. More recent studies suggest a chronic 
inflammatory response may play a key role in the disease pathophysiology. Our study suggests 
that both injured and contralateral vessels are subject to overloads following lymphatic injury. 
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Specifically, collateral formation exposes distal vessels to overloads (pressure) as the collateral 
formation would increase resistance to lymph flow and thus distal vessels would need to work 
harder to transport lymph. Conversely, rerouting to the uninjured vessel exposes contralateral 
vessels to a larger volume of lymph (lymph flow overload) to compensate for the injured 
vessels. This could happen either via the lymphatic rerouting or a connection via the network 
of initial lymphatics distal the injured site.  
The current study paves the way for future studies to investigate the mechanics of 
lymphatic vessels in disease. The rat tail model has the potential to serve as a novel animal 
model for the study of lymphatic remodeling following surgery and swelling, similar to the 
currently available mice models. The size of rat tail lymphatic vessels (~300µ) is suitable 
for mechanical tests, unlike mouse lymphatics models in which these types of tests are very 
challenging. In addition, the location of the vessel in rat tails is also very accessible and 
requires fewer incisions compared to thoracic and mesenteric lymphatics. These vessels 
are all afferent (pre-nodal), hence they mainly drain and pump interstitial fluid from the rat 
tail. Further, the vessels are located adjacent to the skin which makes the tail very suitable 
for in vivo imaging techniques of lymphatic function such as the near-infrared technique. 
For example, our previous computational-experimental study showed that the maximum 
pressure generation to overcome the challenging pressure gradient along a chain is a 
function of the lymphangion number in a chain and consequently, the maximum pressure 
generation measured in rat tails increases from the tip toward the base of the tail [74]. The 
above-mentioned advantages of rat tail lymphatics and the aforementioned biomechanical 
tests make the rat tail model a potential candidate for developing an animal model to study 




CHATER 6. CONCLUSIONS AND FUTURE DIRECTION 
The overall objective of this study was to utilize a combined experimental-computational 
approach to study the effect of mechanical loads on the lymphatic function and long-term 
remodeling associated with the mechanical overloads post-lymphatic injury. We developed 
a novel rat tail model to study lymphatic biomechanics. We believe that this animal model 
can serve the lymphatic field to provide a better understanding of the roles that lymphatic 
biomechanics play in health and disease. Using the rat tail model, we made the observation 
that the lymphatic vessels are under pre-axial stretch in-situ. We used ex-vivo experiment 
on the isolated lymph at vessels from the rat tail to test our hypothesis that the axial stretch 
is a modulator of lymphatic function. We also used two-photon imaging to quantify the 
orientation of collagen fibers in the collecting lymphatic vessels from the rat tail. Analyzing 
imaging data using the curvelet denoising filter and an automated fiber extraction technique 
revealed that the most collagen fibers are aligned in the longitudinal direction. Further, 
immunostaining of lymphatic muscle cells showed that most muscle cells are aligned in 
the circumferential direction, however, actin fiber alignment can be heterogeneous. 
Second, ex-vivo experiments on the isolate lymphatic vessels were performed to study the 
effect of exogenous NO on the lymphatic contractility. Further, we performed biaxial 
testing on the isolated lymphatic vessels from the rat tail. We extended a previously 
developed constitutive framework to model the effect of exogenous NO on the lymphatic 
contractility. This constitutive framework enables us to study the response of lymphatic 
vessels to different mechanical and biomechanical stimuli. We also used near-infrared 
(NIR) technique along with the application of dermal NO donor to study the effect of NO 
 104 
on the lymphatic contractility in the context of a lymphangion chain in-vivo. These 
experiments confirmed that the maximum pressure that can be achieved along with a 
lymphangion chain increase with the tail length and decreases with the application of 
dermal NO. We also performed simulations for a lymphangion chain to show that the 
change in lymphatic muscle force production can explain the in-vivo observations. Third, 
we used the rat tail to develop a novel lymphatic injury model to test our hypothesis that 
the lymphatic vessels remodel in response to injury and associated mechanical overloads. 
In this novel animal model, large segments of rat tail lymphatic vessels were excised from 
one side of the tail while the contralateral vessel on the opposite side was kept intact. Using 
longitudinal NIR imaging we showed that a remodeling response reroutes the injured 
vessel to the dermal lymphatic vessels. Interestingly, most of the injured vessels connected 
to an intact lymphatic vessel to bypass lymphatic injury. The results of biaxial testing and 
histological assessments suggest that the vessels distal to the injured site change their 
biomechanical and material properties. 
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APPENDIX. A NIR IMAGING 
 
Fig. S1 NIR imaging of rat lymphatic vasculature 4 week post surgery. 
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APPENDIX. B  LYMPHANGION MATLAB CODE 






% close all; 
for l=1:1 
    Variables; 















mWSS(i,k)=mean_tau_w(k); %Mean Wall Shear 
Stress () 
mHoop_Stress(i,k)=mean_sigma_w(k); %Mean Hoop 
Stress () 
% mTransmural_Pressure(i)=mean_P;  % Mean 
Transmural Pressure [mmHg] 
% mFlow(i)=mean_Q; % Mean Flow Rate (mL/min) 
  
% mFlow_v1(i)=mean_Q1; % Mean Flow Rate 2nd 
Valve(mL/min) 
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%  i=1:40 
%  mFlow_v2(i)=mean(Qoutflow(:,i)) 
  
colors = {'k','b','k','g','y','c','m'}; 










xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 












% figure (9) 





% xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
%     'FontName','Times New Roman'); 
% ylabel('Mean Flow 
(mL/min)','FontWeight','bold','FontSize',20,... 





% figure (10) 





% xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
%     'FontName','Times New Roman'); 
% ylabel('Mean Transmural Presssure 
[mmHg]','FontWeight','bold','FontSize',20,... 












xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
    'FontName','Times New Roman'); 
ylabel('Mean Total Hoop Stress 
(dyne/cm^2)','FontWeight','bold','FontSize',20,
... 




% figure (12) 





% xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
%     'FontName','Times New Roman'); 
% ylabel('Mean Diameter 
(\mum)','FontWeight','bold','FontSize',20,... 






% figure (13) 





% % xlabel('(Outflow Pressure)-(Inflow 
Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
% %     'FontName','Times New Roman'); 
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% % ylabel('Mean Systolic Diameter 
(\mum)','FontWeight','bold','FontSize',20,... 




% % 'LineWidth',1.5) 
% %  
%  
%  
% %figure (14) 





% xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
%     'FontName','Times New Roman'); 
% ylabel('Mean Diastolic& Systolic Diameters 
(\mum)','FontWeight','bold','FontSize',20,... 






% figure (15) 





% xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',20,... 
%     'FontName','Times New Roman'); 
% ylabel('1st Valve Mean Flow 
(mL/min)','FontWeight','bold','FontSize',20,... 
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xlabel('(Outflow Pressure)-(Inflow Pressure) 
[mmHg]','FontWeight','bold','FontSize',15,... 
    'FontName','Times New Roman'); 
ylabel('2nd Valve Mean Flow 
(mL/min)','FontWeight','bold','FontSize',15,... 







    elseif l==2 
 save('n=1H=100pe05') 
    elseif l==3 
 save('n=1H=100pe10') 
     elseif l==4 
 save('n=1H=100pe15') 
     elseif l==5 








2. cmodel script: 
 
function [p_mod, fz, lq, lr, tq, tq_pas, 






% lz = 1.15; 
% samp = 1; %Number of vessels in the chain 
%  
% % Applied loads 
% % pa = 2*980;  %2.1916*980;    % dynes/cm^2 
(1 cmH2O = 980 dynes/cm^2); 
%  
% % Fluid properties 
% visc = 0.01;        %*0.0001; 
% rho = 1;            %g/cm^3; 
%  
% % Valve resistance parameters (Bertram et al 
2013) 
% RVn = 600*100;          % 
(dynes/cm^2)/(ml/sec)  
% RVx = 12*10^7;      % (dynes/cm^2)/(ml/sec) 
% Po =0; 
% so=0.2; % non-dimensioanl 
%  
%  
%      
%    lz = 1.15; 




% % Fluid properties 






%      
% % Active constitutive model parameters (Alex 
Caulk  2015) 
%  
% lq_max =1.15; 
% lq_o =0.6119; 
% lq_high = 2*lq_max-lq_o; 
% slope0 = 13.0981; 
% int = -4574.4; 
%  
% % Vessel geometry 
% Ro0 = 804/2*0.0001; 
% H0 = 58*0.0001*1.0; 
% L = 0.3046; 
% H= H0; 
% Ro= Ro0; 
% Ri = Ro - H; 
% % Passive 
% b =1.9235e+04; 
% b11 =1.9083e+03; 
% b21 =27.2123; 
% b12 = 4.7515e+04; 
% b22 = 4.8137; 
% b13 = 2.7769e+03; 
% b23 =34.9830; 
% alpha1 =1.5708; 
% alpha2 = 0; 
% alpha3 =  0.8492; 
% alpha4 =  -0.8492; 
%  
%  
% %%%%T act Values%%%%%%%% 
% T_tonic=30000/2; 
% % T_phasic=80000; 
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% % TT=486348.7903/5; 
% % b=0.05 
% % T_tonic=38000+0*TT*b/(1+b); 
%  T_phasic=225000; 




% ww=2; % contraction time 





for i = 1:length(ri) 
    %Calculate loaded thickness from 
incompressibility 
  
    coef_c = -1*H(i)*(2*Ri(i)+H(i))/lz; 
    coef_b = 2*ri(i); 
    coef_a = 1; 
    D1 = [coef_a, coef_b, coef_c]; 
    E1 = roots(D1); 
    F1 = E1(2); 
    h(i) = F1'; 
  
    % Kinematics 
    lq(i) = (ri(i)+h(i)/2)/(Ri(i)+H(i)/2); 
    lr(i) = 1/(lq(i)*lz); 
    Fqq = lq(i); 
    Fzz = lz; 
    Frr = lr(i); 
    Crr = Frr^2; 
    Cqq = Fqq^2; 
    Czz = Fzz^2; 
    Err = (Crr-1)/2; 
    Eqq = (Cqq-1)/2; 
    Ezz = (Czz-1)/2; 
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    lambda2_k1 = Cqq*(sin(alpha1))^2 + 
Czz*(cos(alpha1))^2; 
    lambda2_k2 = 0*Cqq*(sin(alpha2))^2 + 
Czz*(cos(alpha2))^2; 
    lambda2_k3 = Cqq*(sin(alpha3))^2 + 
Czz*(cos(alpha3))^2; 
    lambda2_k4 = Cqq*(sin(alpha4))^2 + 
Czz*(cos(alpha4))^2; 
  
    %Strain energy function proposed by 
Holzapfel for four fiber families 
    tr_hat = 2*Crr*b; 




(sin(alpha1))^2) + ... 
        0*b12/2*exp(b22*(lambda2_k2-
1)^2)*(Cqq*(sin(alpha2))^4 + 
Czz*(sin(alpha2))^2*(cos(alpha2))^2 - 
(sin(alpha2))^2) + ... 




    tz_hat = 2*Czz*(b + 
b11/2*exp(b21*(lambda2_k1-
1)^2)*(Cqq*(sin(alpha1))^2*(cos(alpha1))^2 + 
Czz*(cos(alpha1))^4 - (cos(alpha1))^2) + ... 
        0*b12/2*exp(b22*(lambda2_k2-
1)^2)*(Cqq*(sin(alpha2))^2*(cos(alpha2))^2 + 
Czz*(cos(alpha2))^4 - (cos(alpha2))^2) + ... 
        b13*exp(b23*(lambda2_k3-
1)^2)*(Cqq*(sin(alpha3))^2*(cos(alpha3))^2 + 
Czz*(cos(alpha3))^4 - (cos(alpha3))^2)); 
  
    % Calculate active stress 
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    tq_pas(i) = tq_hat - tr_hat; 
    tz(i) = tz_hat - tr_hat; 
  
    % Calculate active stress 
    if lq(i) <= lq_high && lq(i) >= lq_o; 
        tq_act(i) = Tact(i)*lq(i)*(1-((lq_max-
lq(i))/(lq_max-lq_o))^2); 
    else 
        tq_act(i) = 0; 
    end 
     
  
  
    tq(i) = tq_act(i) + tq_pas(i); 
  
    p_mod(i) = h(i)/ri(i)*(tq(i) + pex) + pex; 















% error(1)= (cmodel(R(1),Tact(1)) - 
p_mod(1))*10000; 
% error(2)= (cmodel(R(2),Tact(2)) - 
p_mod(2))*10000; 
4. diameterp Script: 
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if nLymph == 1 
    F(1)=cmodel((p(3)/1),Tact(1),pex(1))-
(p(1)+p(2))/2; 











    F(1)=cmodel((p(3)/1),Tact(1),pex(1))-
(p(1)+p(2))/2; 









    F(4)=cmodel((p(6)/1),Tact(2),pex(2))-
(p(4)+p(5))/2; 












     
        fac=1; 
     F(1)=fac*(cmodel((p(3)/1),Tact(1),pex(1))-
(p(1)+p(2))/2); 









     
for i=2:nLymph-1 
  
    F(3*i-
2)=fac*(cmodel((p(3*i)/1),Tact(i),pex(i))-
(p(3*i-2)+p(3*i-1))/2); 








































5. fandv Script: 




     F(1)=pm(1)-(p(1)+p(2))/2; 







        
    if k==1 
        F(1)=pm(1)-(p(1)+p(2))/2; 




    elseif k==nlymph  
    F(2*k-1)=pm(k)-(p(2*k-1)+p(2*k))/2; 




     
    else 
    F(2*k-1)=pm(k)-(p(2*k-1)+p(2*k))/2; 





     




     
     










x0(1:nlymph)=.01 ;%Initial Guess for 
Diameter(cm) 
pa=pa_mmhg*1333.2239; 
pb=pb_mmhg*1333.2239; %inflow&outflow pressure 
[mmHg] 
%N=201% number of time steps 
dt=0.01;%2*ww/(N-1); %time step 












    if i==1 
        k=1:nlymph 
p_mod=(pa+pb)/2; 
p_mod(k)=pa+(pb-pa)*k/(nlymph*2) 















    if nlymph==1 
    xo(1)=(pa+pm(1))/2;     
    xo(2)=(pb+pm(1))/2; 
    else 
    if (k==1) 
        xo(1)=(pa+pm(1))/2;     
        xo(2)=(pb+pm(nlymph))/2; 
    elseif (k==nlymph) 
        xo(2*k-1)=(pm(k)+pm(k-1))/2; 
        xo(2*k)=(pm(k)+pb)/2; 
    else  
        xo(2*k-1)=(pm(k)+pm(k-1))/2; 
        xo(2*k)=(pm(k)+pm(k+1))/2; 
    end 




% x0 = [(pa+pm)/2,(pb+pm)/2]; 
f = @(p)fandv(p,pm,pa,pb,Rf,nlymph); 
% x0 = [0,0]; 




% g = @(p)fandvb(p,pm,pa,pb,Rf); 
% x0 = [0,0]; 
% % x = fsolve(fun,x0)fandv(p,pm,pa,pb,Rf) 









[Q1,Q2] = valveflow(pa,pb,p1,p2,nlymph); 
% p1=x(1); 
% p2=x(2); 








    else 
         i 
          
        ddt=dt*(i-1); 
        time(i)=ddt; 
%     ( 1-  cos(2*pi*ww*(ddt))) 
phi=0.1 
 for k=1:nlymph; 
     Tact(k)=Ta(i,k) 
%       Tact(k)=( 1- cos(phi*(k-
1)+2*pi*1/ww*(ddt)))*T_phasic/2+ T_tonic; 
      T(i,k)=Tact(k); 
        pex(k)=0*( 1-  cos(phi*(k-
1)+2*pi*1/ww*(ddt)))*PEX+PEX; 
        Pex(i,k)=pex(k); 
 end 
       
     for  k=1:nlymph 
       R(i,k)=r(i-1,k) ; 
       Ro(k)= R(i,k); 
       x1(3*k-1) = p1(i-1,k);   
       x1(3*k-2) = p2(i-1,k);   
       x1(3*k) = R(i,k);     
     end 
      f = 
@(p)diameterp(p,pa,pb,Tact,Ro,dt,nlymph,pex); 
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      [x,fval] = lsqnonlin(f,x1); 
       k=1:nlymph      
      r(i,k)= x(3*k); 
      p1(i,k)=x(3*k-2); 
      p2(i,k)=x(3*k-1); 
      p11(k)=p1(i,k); 
      p22(k)= p2(i,k); 
      R_t(i,k)=r(i,k); 
      rr=r(i,k); 
      for k=1:nlymph 
   %   p_t(i,k)=cmodel(r(i,k),T(i,k),pex(k)); 
      [p_t(i,k),fz(i,k), lq(i,k), lr(i,k), 
tq(i,k), tq_pas(i,k), tq_act(i,k), tz(i,k), 
h(i,k)]=cmodel(r(i,k),T(i,k),pex(k)); 
  
      end 
%     [p_t(i),fz(i), lq(i), lr(i), tq(i), 
tq_pas(i), tq_act(i), tz(i), 
h(i)]=cmodel(R_t,Tact); 
  
      [Q1,Q2] = 
valveflow(pa,pb,p11,p22,nlymph); 
%       qq(i)=Q1 
%       qqq(i)=Q2 
       k=1:nlymph 
       Q_1(i,k)=Q1(1,k); 
       Q_2(i,k)=Q2(1,k); 
       Q_m(i,k)=(Q_1(i,k)+ Q_2(i,k))*0.5; 
     
% figure (30) 
% plot(Q_1) 
%  




% % figure (29) 
% % plot(r) 
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%  







wss(:,k) = 4*visc*Q_m(:,k)./(pi*r(:,k).^3); 
mean_tau_w(k) = mean(wss(201:N,k)); % 
mean_sigma_w(k) = mean(tq(201:N,k)); % 
Volume=pi*r(201:N,k).^2*L*lz; 
Volumeo=pi*r(:,k).^2*L*lz; 
mean_Q2 = mean(60*Q_2(201:N,nlymph)); % Mean 
Flow Rate (mL/min) 
Qout=60*Q_2(201:N,nlymph); 
  
colors = {'k','b','k','g','y','c','m'}; 














    'FontName','Times New Roman'); 
ylabel('Diameter 
(\mum)','FontWeight','bold','FontSize',25,... 





legend('Collapsible','3 point Model (Bertram 
2014)','Poiseuille') 
% legend() 



























    'FontName','Times New Roman'); 
ylabel('Pressure(cmH_2O)','FontWeight','bold','
FontSize',25,... 






legend('Collapsible','3 point Model (Bertram 
2014)','Poiseuille') 













    'FontName','Times New Roman'); 
ylabel('1st Valve Flow 
Rate(mL/min)','FontWeight','bold','FontSize',25
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legend('Collapsible','3 point Model (Bertram 
2014)','Poiseuille') 











    'FontName','Times New Roman'); 
 128 
ylabel('2nd Valve Flow 
Rate(mL/min)','FontWeight','bold','FontSize',25
,... 




legend('Collapsible','3 point Model (Bertram 
2014)','Poiseuille') 
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7. Variables Script 
lz = 1.10; 
samp = 1; %Number of vessels in the chain 
  
% Applied loads 
% pa = 2*980;  %2.1916*980;    % dynes/cm^2 (1 
cmH2O = 980 dynes/cm^2); 
  
% Fluid properties 
visc = 0.01;        %*0.0001; 
rho = 1;            %g/cm^3; 
  
% Valve resistance parameters (Bertram et al 
2013) 
% RVn = 600*100;          % 
(dynes/cm^2)/(ml/sec)  
% RVx = 12*10^7;      % (dynes/cm^2)/(ml/sec) 
% Po =0; 
% so=0.2; % non-dimensioanl 
  
RVn = 6*10^4;          % (dynes/cm^2)/(ml/sec)  
RVx = 10^7;      %10^5% (dynes/cm^2)/(ml/sec) 
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Po =0; 






% Fluid properties 





     
% Active constitutive model parameters (Alex 




 lq_high = 2*lq_max-lq_o; 
% slope0 = 13.0981; 
% int = -4574.4; 
  
% Vessel geometry 
Ro0 = 252/2*0.0001; 
H0 = 19*0.0001; 
L = 0.276; 
H= H0; 
Ro= Ro0; 





b12 = 0; 
b22 = 0; 
b13 = 1.9*10^4; 
b23 =5.93*10^-4*10^4; 
alpha1 =0; 
alpha2 = 0; 
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alpha3 =  25.28*3.14/180; 
alpha4 =  -alpha3; 
  
C=0.8 
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